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The tissue-level response to pathogens involves an intricate series of signal transduction 
events, influenced by immune and healing mediators that alert the host to danger and eliminate the 
infection. Disruptions to normal signaling events can compromise the host’s ability to respond and 
lead to the development of chronic infections that cannot be resolved without clinical intervention. 
Prolonged inflammation due to chronic infection can damage tissues and compromise healing 
processes, thus, the interactions of immune and healing mediators in signaling cascades are 
intimately linked to tissue health outcomes. Studying signaling networks relevant to these 
responses provided a more thorough understanding of localized tissue health to identify the drivers 
of disruptions to signaling cascades, and this knowledge can lead to the development of improved 
diagnostic and therapeutic biomarkers to combat chronic infections. The work presented here 
focused on elucidating the relationships between immune and wound healing factors in an in vivo 
rodent model and a clinical cohort to understand the tissue-level responses to chronic inflammation 
and infection. Specifically, extracellular inflammatory immune responses (i.e., cytokines and 
chemokines) related to intracellular signaling (i.e., phosphorylation of proteins) were investigated 
to identify alterations in native responses compared to those provoked by chronic inflammation 
and infection. Reponses in native tissues were compared to tissues with inflammatory and 
infectious stimuli to test if levels of immune related cytokines were elevated in response to chronic 
joint infections. Wound healing phosphoproteins were also included to look for shifts in wound 
healing-related processes across groups. Traditional statistical approaches and network analysis 
were used to dissect these complex biological datasets and identified drivers of network disruptions 
in response to inflammation and infection. The spatial analysis suggested that changes in biological 
responses were related to proximity to inflammation and infection, and the degree of response 
differed across spatial gradients, which demonstrated the ability for these chronic insults to affect 
disparate tissues in a clinically-relevant manner. The objective of this research and future related 
research is to facilitate new clinical strategies to combat chronic infection, and monitoring 
alterations to cell signaling pathways in this work highlighted the value of using network analysis 
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 Overview of biological cell signaling 
1.1.1 Components of biological cell signaling 
Cells respond to cues from their environments through relays of complex signaling 
networks, creating a path for adaptation towards survival, proliferation, or death. Understanding 
these signal transduction networks is crucial when studying complex biological responses, such as 
those observed in chronic inflammation and infection. Cell signaling was first observed in 
hormonal studies by Claude Bernard in 1855, who described that hormones released into the 
bloodstream produced effects in distant cells [1]. Bernard created a new concept of the “milieu 
intérieur” which described regulation through complex cellular feedback signaling to maintain 
homeostasis. Specifically, he described how interstitial fluid in the extracellular environment can 
provide a protective barrier for cells and tissues to preserve stability in response to stimuli. Since 
then, biological signaling has been pursued by a wide variety of biochemical researchers, and the 
term “signal transduction” as it is known now was first coined in the 1970s, providing the basis 
for the modern model of cell signaling, consisting of receptors, transducers, and amplifiers [2]. 
When a signal ligand binds to a receptor, this information is transduced into the intracellular space 
and amplified within the cell to produce a response, and examples of signal ligands include growth 
factors, hormones, cytokines, neurotransmitters, and many other small molecules. The release of 
these signals can reflect perturbations to the homeostatic state, and signal transduction is the 
primary means for communicating this information within and between cells. A simplified diagram 






Figure 1. 1. Cellular Response to External Stimuli. When a change occurs in the external 
environment, cells respond to this input through receptors. Sensors convert this to communicate 
signals that are meaningful to the organism. A controller compares this signal to a desired “set 
point” of the homeostatic state to alert the cell if there is a discrepancy. Activators interact with 
effectos to initiate a response, and this feedback communicates to the original receptor whether or 
not homeostasis has been achieved. This phenomenon describes how external cues to initiate 
changes within the cell. 
 
Signal transduction provides instructions for the cell relevant to cell communication, cell 
cycle control, pathogen sensing, neurotransmission, and many other biological processes that 
affect target cells within the organism through the initiation of one of four modes of signaling: 
autocrine signaling, direct signaling, paracrine signaling, and endocrine signaling [3]. Autocrine 
signaling is a self-activation in which a ligand acts on the same cell that released it, as shown in 
Figure 1.2.a. Direct cell signaling, as the name suggests, involves direct communication between 
cells in contact with one another and is often mediated by gap junctions, which are clusters of 
intercellular channels that allow direct transfer of small molecules and ions. This type of signaling 
is alternatively referred to as juxtacrine signaling (Fig. 1.2.b). Signaling can also occur between 
neighboring cells not in direct contact via paracrine signaling. In paracrine signaling, signal ligands 
diffuse a short distance through the extracellular space to activate the target cell (Fig. 1.2.c). Finally, 
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signaling can occur between distant cells. Endocrine signaling is achieved through secreted 
molecules that travel through the bloodstream to activate target cells that are further away from 
the signaling cell. This type of signaling is often utilized by hormones (Fig. 1.2.d). 
 
Figure 1. 2. Modes of cellular signal transduction. Signals can be transmitted through four primary 
mechanisms: (a) autocrine signaling, in which a ligand activates a receptor on the same cell that 
released it; (b) direct signaling between two cells in contact with one another; (c) paracrine 
signaling, in which the ligand travels a short distance to bind to a receptor on a target cell; and (d) 
endocrine signaling occurs when ligands travel through the bloodstream to activate target cells. 
 
Signaling networks can produce immune-related responses through any of these four 
mechanisms, and sometimes the multiple mechanisms can be employed by the same molecule. 
Cytokines represent a diverse group of immune-related molecules that participate in these 
signaling pathways to transmit intracellular and intercellular signals and are an integral part of 
inflammation and the response to pathogens. The term “cytokine” represents a broad group of 
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chemokines, interferons, interleukins, lymphokines, and tumor necrosis factors that play critical 
roles in cell communication. They typically achieve this through autocrine (Fig. 1.2a) and 
paracrine (Fig 1.2c) signaling but can simultaneously use multiple signaling mechanisms. 
Cytokines are often associated with localized signaling to alert and recruit immune cells [4], but 
many cytokines have illustrated communication via long-range endocrine signaling (Fig. 1.2.d), 
such as interleukin(IL)-1 transport through the bloodstream to alert distant cells to the presence of 
pathogens [5].  
 
Once an initiating signal has been produced through any of these mechanisms, it can bind 
to cell surface receptors. Cell surface receptors traverse the plasma membrane and have specific 
signal binding domains in the extracellular space, converting external stimuli into an intracellular 
signal. Upon binding, there is a conformational change to activate the receptor’s cytoplasmic 
domain, often provoking enzyme activity from kinases, phosphatases, and adaptor molecules [6]. 
Intracellular receptors are present on the nucleus, cytosol, mitochondria, endoplasmic reticulum, 
and Golgi apparatus and serve to propagate and amplify the signaling events initiated through this 
extracellular binding. Intracellular binding targets widely vary and frequently affect transcription 
and gene expression [3], illustrating the connection between external stimuli and intracellular 
signal transduction pathways, such as activation of the mitogen-activated protein 
kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway and the Janus kinase/signal 
transducers and activators of transcription (JAK/STAT) pathway. Extracellular signals (e.g., 
cytokines) produced in response to stressors, like inflammation and infection, ultimately affect the 




External cues can produce various effects in cells, highlighting the importance of 
specificity in these signal transduction cascades. Specificity in cell signaling events is a hallmark 
of ligand binding and allows the cell to be highly adaptive while also producing diverse responses, 
and this specificity is achieved in two ways. First, receptors exhibit a high affinity for ligands, 
resulting in specificity of the ligand binding interaction. Receptor specificity depends on the 
ligand’s binding affinity and binding domains, so these specific ligand interactions ultimately 
dictate the biological effect. Specificity in cytokine binding to members of the JAK/STAT family 
allows for diverse bioactivity, as is the case with the IL-6 versus IL-10. While both cytokines 
activate STAT3, IL-6 produces pro-inflammatory effects while IL-10 has an anti-inflammatory 
role [8]. Another mechanism to achieve specificity in cells is the varied expression of types and 
proportions of receptors, both inside and outside the cell. Therefore, cell types can be specialized 
for specific functions depending on the receptors expressed. Immune-related cells express specific 
and distinct cell surface receptors critical for the host response to pathogens. Antigen-presenting 
cells (APCs) are essential in the early response to pathogens, and they respond to environmental 
stimuli through toll-like receptors (TLRs) for pathogen identification [9]. Receptor expression 
allows diversity of signaling events related to cell type. 
 
Signal transduction networks in the immune response to infection involve an 
extraordinarily complex system of cascades, and actions of these signaling mediators have 
consequences for cellular fate. The binding of extracellular signals affects intracellular signaling 
and produces bioactivity that directs the cell towards survival or death. Specificity of cell signaling 
is crucial because it allows cells to perceive a wide range of stimuli while maintaining strictly 
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regulated biological outputs. Ultimately, these tightly regulated networks enable external cues and 
stressors to determine cell fate. 
 
1.1.2 Interactions of cell signaling pathways 
While specific ligand-receptor interactions and varied receptor expression allow for a high 
degree of specificity, interactions between signaling pathways add another layer of complexity, 
involving mutual influences of signals originating from disparate pathways. Following the initial 
signal relay through receptor binding, activation of small molecule second messengers like cAMP, 
calcium, and DAG can promote second messenger interactions with other pathways. The extent of 
pathway interactions during immune and inflammatory responses is unknown, but evidence 
suggests it occurs between different inflammatory cell types, immune-related cytokines, and in 
intracellular signaling pathways like MAPK/ERK and JAK/STAT [10]. Overlap and integration 
of cell signaling pathways primarily occur in three different ways: (1) multiple inputs that converge 
to produce a response, (2) signal gating, in which a signal output from one pathway is regulated 
by a second pathway, and (3) the establishment of feedback loops. All three of these regulating 
mechanisms have been observed in signaling networks related to the immune response to infection. 
These types of interactions between cell signaling pathways highlight the functional specificity of 
signaling mediators, a term to describe how structurally similar proteins can produce distinct 
outcomes, introducing more diversity in response.  
 
Coincidence detection is the convergence of two cellular pathways to produce one output; 
the important distinction from single pathway signaling is that both inputs must be present to elicit 
a response, and the combined response is different than the individual products of each activation 
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(Figure 1.3a). T cell survival is dependent on T cell antigen receptor signaling convergence with 
IL-2 and IL-7 cytokine activation, and, without the presence of IL-2 or IL-7, pro-apoptotic proteins 
FasL and Bim are up-regulated, leading to apoptosis of T cells [11]. Coincidence detection of these 
cytokines in conjunction with T cell antigen receptor signals is critical for T cell survival. Many 
other examples exist in complex, highly conserved signaling pathways related to immunity, and 
these add diversity to the roles of signaling molecules. In response to different cytokines, 
JAK/STAT pathways can be activated in immune cells to produce distinct, cell-type-specific 
responses [12]. While many of these signaling events are not well defined, the dependence on 
multiple pathway convergence does enlighten the diversity of cell signaling outputs. 
 
Gating is another common form of pathway interaction in which one signaling pathway 
evokes a response and is modulated by a second pathway, resulting in either activation or inhibition 
of the first pathway (Fig. 1.3b). An important feature of regulation via gating is that one signaling 
pathway can regulate the flow of another pathway, thus stimulating or prohibiting its response [13]. 
The GTP binding protein Ras influences the ERK proliferative response through this mechanism 
via the second messenger cAMP. When cAMP levels increase, protein kinase A (PKA) is activated, 
which subsequently phosphorylates and deactivates Raf, leading to decreased ERK stimulation 
and reduced proliferation [14]. The gating mechanism creates a complex web of regulation to 
connect related cellular processes, ultimately allowing extracellular ligand action from one 




Feedback loops establish a direct relationship between cellular outputs and the initial input, 
and they are influential in signaling networks in homeostasis [15], metabolism [16], transcriptional 
regulation [17], and immune response to infection [18]. Negative feedback loops are a hallmark of 
almost all known signaling pathways, attenuating the allowed output through positive or negative 
feedback. The output signal is produced and converted before being fed back into the input, and 
this new input can subsequently activate or deactivate the initial pathway (Fig. 1.3c). This type of 
feedback is necessary for adaptation to the extracellular environment, as eukaryotic cell machinery 
is built to respond to changes, and cytokine-mediated inflammation employs feedback loops to 
regulate the degree of inflammation in response to infection or insult. In response to pathogens, 
IL-1β is released as an early initiator of infection, and subsequent IL-1β signaling elevates levels 
of its receptor, IL-1Ra, which- in turn- negatively regulates the production of IL-1β and allows a 
controlled reduction of the immune response [10]. In this way, the cells respond adaptively to 
changes in their environment rather than solely relying on absolute amounts of a particular signal. 
Positive feedback occurs when the output is fed back into the input unchanged, thereby amplifying 
the signal, and this feedforward regulation is also common in immune signaling [19]. In complex 
networks, signaling pathways can have multiple feedback loops and mixed loops, which contain 
both positive and negative components. 
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Interactions of cell signaling pathways add complexity and allow more variety in biological 
outputs. Coincidence detection, gating, and feedback loops illustrate three mechanisms by which 
cells can diversify the responses based on the presence of two or more signaling molecules, which 
may partially explain the benefit of the pleiotropic and redundant nature of signaling molecules 
(e.g., cytokines) and how this relates to functional specificity [8]. Gaining insights into the 
interactions of disparate immune-related signaling pathways will certainly enlighten 
understanding of the correlations between immune signals and responses when multiple cytokines 
and immune-related mediators are involved. 
 
Figure 1. 3. Interactions of Cell Signaling Pathways. Overlap of cell signaling pathways can 
produce a response in different ways. A) Coincidental detection involves two signals converging 
to produce one response. B) Gating is a mechanism in which one signal pathway (Signal A) can 
stimulate or inhibit another pathway (Signal B).  C) Feedback loops allow a signal (Signal C) to 
activate a pathway (Signal A) while also providing regulation of that pathway (Signal B). 
 
1.1.3 Protein phosphorylation in cell signaling 
Post-translational modifications (PTMs) are a frequently observed mechanism for 
regulating protein activity in cell signaling cascades, primarily via small covalent changes to their 
chemical structures (Figure 1.4). PTMs add diversity to the proteome and can modify protein 
activity through the addition of complex molecules, peptides, chemical groups, and cleavage of 
B C A 
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functional subunits [20]. The addition of these groups often acts as an on/off switch for protein 
activity, and PTMs serve as regulatory mechanisms for many signal transduction pathways, often 
through previously-discussed regulatory mechanisms like feedback loops (Fig. 1.3). Protein 
modifications can also regulate activity via gating by inducing conformational changes that lead 




Figure 1. 4. Mechanism of phosphorylation and dephosphorylation. Kinases perform a hydrolysis 
reaction to covalently attach a phosphate group from ATP to a protein at polar R groups of amino 
acids. ATP coordination with Mg2+ (shown in green) is essential for the transfer of a phosphate 
group. Phosphorylated proteins can be dephosphorylated by phosphatases, which hydrolyze the 
phosphoric acid monoesters, which results in ADP converting back to ATP. A free hydroxyl group 
remains on the protein after removal of the phosphate group. Reproduced with permission from 





Protein phosphorylation was one of the first PTMs identified, and it has a role of regulation 
in key biological processes through simple biding of a phosphate group. In 1956, Krebs and Fischer 
demonstrated that reversible phosphorylation controlled glucose storage [21]. Through kinase 
activity, phosphate groups are added to polar R groups of serine, threonine, or tyrosine residues. 
The addition of a PO4 group causes a conformational change, which can aid or prevent protein-
protein interactions. Phosphorylation is negatively regulated by phosphatase enzymes, which can 
remove the phosphate group, and the mechanism of phosphorylation/dephosphorylation is 
illustrated in Figure 1.4 [22]. These processes influence energy availability, making 
phosphorylation an especially important PTM in cellular signaling. Energy availability is 
predictive of cellular fate, and this can be experimentally observed by monitoring protein 
phosphorylation as a marker of mitochondrially-driven kinase activity [23]. Phosphorylation has 
been studied in bacterial and mammalian systems and has demonstrated a role in a broad range of 
cellular processes, such as membrane transport, protein degradation, and enzyme regulation. The 
biological implications of these activities are important in bioenergetics, cell proliferation, and the 
development of disease states. Monitoring phosphorylation events, especially concerning immune 
signaling, has proven useful in understanding the disrupted cell signaling events that can delay 
healing [24]. 
 
Historically, cell signaling research has focused on distinct pieces of signaling cascades to 
understand specific regulators, but spatial and temporal regulation of these signals, including 
PTMs, is an increasingly compelling problem to study in the field of biochemistry. New 
developments in multi-‘omics technologies have made the investigation of a large number of 
related targets more accessible than ever before. Recent research efforts have focused on 
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understanding not only the individual components of cell signaling pathways, but they have also 
expanded to investigate interactions between pathways. Many researchers have begun to approach 
this problem by studying signaling pathways as a whole to understand the influence of individual 
components and their respective relationships. Future research can continue to understand how 
these complex signaling pathways interact to produce diverse biological consequences. 
 
 The immune response to infection 
1.2.1 Acute immune response 
The mammalian immune system serves to protect the host from harmful pathogens, and 
this response involves the coordination of multiple cell signaling pathways, including cytokine 
immune mediation [25], MAPK/ERK activation [26], and JAK/STAT signaling [27]. The immune 
system’s primary function is to eliminate pathogenic microbes if they breach the mucosal barrier, 
and both innate and adaptive immune strategies are utilized to identify and target harmful 
pathogens via pathogen recognition receptors (PRRs). PRRs recognize specific structures of 
pathogens known as pathogen-associated molecular patterns (PAMPs), and this initiates a cascade 
to eliminate the pathogen [28]. The acute immune response is the initial attempt to combat the 
infection.  Cytokines are essential mediators of this response, acting as communicators to recruit 
immune cells and resolve infection through short-range autocrine signaling and paracrine signaling 
[4, 5], and long-range endocrine signaling [29]. Cytokines are produced by immune-specific cells 
such as B lymphocytes, T lymphocytes, macrophages, and mast cells [30], or by endothelial cells, 
fibroblasts, and stromal cells [31], which are all capable of releasing cytokines as an “alert” to the 
localized environment. Murine models have established that this acute response period commences 
at pathogen recognition and can persist to approximately 21 days post-infection [32]. The initial 
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inflammatory response activates NF-κB and MAPK pathways, resulting in the production of 
cytokines IL-1α, IL-1β, TNF-α, IL-2, and IL-18 [33]. These cytokines regulate the activities of T-
helper cells, macrophages, and neutrophils to control immune cell differentiation and maturation 
[34], interact with growth factors that control angiogenesis [35], and influence cellular fate by 
activation of NF-κB signaling to regulate apoptosis [33]. Extracellular cytokines bind to receptors 
to propagate these intracellular signaling cascades, impacting the transcription of proteins central 
to these cellular processes. Cytokines like IL-6, IL-10, IL-12, IL-4, IL-13, and IFN-α/β activate 
STAT proteins, activating TH1-related responses to propagate immune cell activity [27]. The 
effects of early cytokine activity produce a robust inflammatory response that is beneficial for 
resolving pathogens, but it is somewhat unregulated. 
 
The potent inflammatory response elicited early on by cytokines can combat bacterial 
invasion, but it can also result in tissue damage if left unregulated. The initial cytokine response 
functions much like a sensor of infection, followed by a more targeted approach adopted by the 
immune system following this uncontrolled release of cytokines, with careful control of activity 
through gating, feedback mechanisms, and signaling crosstalk. The downstream activity of 
cytokine activation through receptor binding often serves as a negative regulator of cytokine 
activity [10], so cells can adapt following the initial cytokine surge. Sophisticated communication 
between multiple cell signaling pathways, including MAPK/ERK, NF-κB, and JAK/STAT 
signaling [29] to balance the activity of pro-inflammatory and anti-inflammatory cytokines 
facilitate this adaptation to resolve infection most efficiently. The cytokine response to infection 
persists until the infection has been eliminated from the host. Balancing the initial inflammatory 
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response and activation of effectors achieves pathogen resolution without producing harmful 
effects in surrounding tissues.  
 
1.2.2 Chronic infections and immune response 
When the acute response to infection cannot resolve or fully eliminate the pathogen, the 
infection can transition into a chronic state, and both environmental and biological factors can 
contribute to this outcome. The causes for failure of acute response are not fully understood, but 
several risk factors have been identified, including autoimmune disease, obesity, and age [36]. 
During infection, a critical balance must be struck by immune mediators to prevent tissue damage, 
but chronic infections result in persistent activation of inflammation until immune cells become 
exhausted [37], causing a variety of consequences for cell signaling. In chronic bacterial infections, 
disrupted immune responses are marked by continuous stimulation of Th1/Th17 lymphocyte pro-
inflammatory mediators and a failure of Th2 anti-inflammatory mediators [38]. Reduction of anti-
inflammatory influence causes the signaling networks to be shifted towards excessive cell death, 
which disrupts immune cells’ ability to resolve the infection and damages the surrounding tissue, 
thereby perpetuating the infection. Network analysis of chronic infection states has revealed 
distinct shifts away from growth, proliferative, and immune differentiation metabolic activities 
hallmark of the acute response towards heavy metabolic activity with increased progression 
towards apoptosis and programmed cell death [39]. 
 
Errant cell signaling has also been attributed to failures in signal transduction regulatory 
loops. In chronic infections, the deactivation of crucial downstream regulators of cytokine activity 
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has been observed, such as dephosphorylation in c-Jun, p38, and ERK1/2 [40]. Phosphorylation 
of these proteins typically serve as negative regulators of inflammatory cytokine activity, but this 
represents one example of disrupted cell signaling cascades in chronic infection states. While this 
has not been explicitly linked to the disrupted cytokine activity and reduced anti-inflammatory 
capacity, it introduces a potential explanation for how a shift in the cytokine pro- and anti-
inflammatory balance may eventually stimulate increased cell death [41]. The reduced capacity of 
immune cells observed in persistent infection suggests that these signaling disruptions overwhelm 
host immunity, causing an inability to resolve the infection. Disruptions to signaling networks can 
be influenced by infection duration, infecting organism, and tissue type. 
 
1.2.3 Bacterial hijacking of host cell signaling 
While the mechanisms of disrupted cell signaling in infection are not entirely understood, 
microbial agents have demonstrated the ability to hijack host cell signaling machinery to decrease 
the efficacy of host defense strategies, and some of these effects play a role in the transition to 
chronic infection. One way bacteria affect host immune response is by producing toxins that 
corrupt cell signaling cascades and dampen the effects of mediators critical for the early 
recognition of pathogens [42]. Without this initial alert and warning to the host immune system, 
pathogens can go undetected, ultimately disrupting the normal sequence of pathogen clearance via 
immune signaling [43]. The VacA cytotoxin of H. pylori has been shown to delete genes in host 
immune cells vital to inflammatory response, blocking several early pro-inflammatory cytokines 
involved in early infection response like IL-6 and IL-8 [44]. Similarly, M. tuberculosis subverts 
macrophages to downregulate TNF-α, IL-12, and IL-1β and shut down pro-inflammatory 
responses [45]. Bacteria like Yersinia ssp., Shigella ssp., and E. coli produce other peptides or 
17 
 
small molecules that can interfere with cell signaling cascades by inhibiting critical signaling 
mediators and coopt entire signaling systems, resulting in a decreased ability for pathogen 
recognition [46]. These bacteria cause deleterious effects through the exploitation of host signaling. 
 
Bacterial hijacking of cell machinery has been observed for many pathogens, and the exact 
mechanisms of disruption vary depending on infecting organism and the extracellular environment. 
The presence of non-infectious inflammatory stimuli, such as those associated with obesity or 
chronic inflammatory conditions, can influence how bacteria interact with host cell signaling 
pathways. The unique environment created by inflammatory disease coupled to infection is more 
complex than bacterial invasion alone because the cascades initiated by recognition of PAMPs 
often overlap with those triggered by damage-associated molecular patterns (DAMPs) from non-
infectious stimuli. Both PAMPs and DAMPs cause persistent activation of pro-inflammatory 
mediators through activation of NF-κB and p38 MAPK pathways [47], so the overlap of chronic 
inflammatory disease and infection may not have the same effect as the sum of the individual 
insults. The intersection of chronic inflammatory conditions and subsequent infection is not well 
studied, but obesity and rheumatoid arthritis are two conditions that are frequently plagued by 
concurrent infection. Obesity impairs the immune response to infection by promoting T cell 
senescence, which affects the production of early pro-inflammatory cytokines [48]. Although the 
mechanistic effects have not been explicitly studied, increased incidence of chronic infection in 
obese patients compared to non-obese individuals suggest the suppressive effects on cell signaling 
may be advantageous for bacterial interference with signaling cascades. Rheumatoid arthritis is 
another disease that alters immune-related cell signaling and has been associated with an increased 
risk of chronic infection. Several cytokines, like 1L-1α, IL-1β, and TNF-α, are up-regulated in 
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arthritis, and chronic activation of these pro-inflammatory mediators can cause damage to bone 
and cartilage [49]. Damaged tissue creates an ideal environment for infection, so the compromised 
tissue combined with immunomodulatory effects of the disease may create an environment that is 
conducive to bacterial disruption of immune function. Altered immune signaling when both 
infectious and non-infectious sources are present continues to be an intriguing problem, and the 
rising prevalence of chronic inflammatory conditions like obesity and rheumatoid arthritis in the 
United States makes them an extremely relevant problem to study [50]. 
 
 Disruptions to cell signaling pathways observed in pathological conditions 
1.3.1 Periprosthetic joint infection (PJI) and immune signaling 
Elucidating changes in cell signaling networks provoked by chronic infection may provide 
a better understanding of the drivers of dysregulation in a range of clinical pathologies. One 
example of a chronic infection is periprosthetic joint infection (PJI), a devastating post-operative 
complication following total knee arthroplasty (TKA) and total knee revision (TKR) procedures, 
and these infections have high clinical relevance for the field of Orthopaedics. Over one million 
joint revision procedures are conducted in the United States every year, and the popularity of TKA 
procedures is projected to grow rapidly [51]. While joint replacement is a life-enhancing procedure 
for many people, infections can develop and affect both the joint prosthesis and surrounding tissues. 
PJIs occur in approximately 2% of joint revisions and affect tens of thousands of patients per year, 
imposing high emotional and financial burdens on these individuals [52, 53]. They can be caused 
by a variety of bacteria, but Staphylococcus aureus is the most common pathogen implicated [54]. 
Many PJIs become chronic due to bacteria’s ability to evade host response by forming protective 
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biofilm barriers and interference with host immune efforts [55], and changes in cytokine and 
immune signaling pathways have been observed.  
 
The localized PJI environment is affected both by inflammation due to foreign body 
implants and the modulatory effects of the bacteria. Surrounding tissues often exhibit elevated 
levels of localized cytokines due to prosthesis alone [56], and the presence of S. aureus can have 
additional effects on host adaptive immunity. PJIs due to S. aureus have been shown to dampen 
leukocyte activity and reduce phagocytosis following bacterial invasion. S. aureus also employs 
countermeasures, including provocation of anti-inflammatory mediators, to combat the robust pro-
inflammatory response of surrounding tissues [57], similar to previously discussed bacterial 
hijacking strategies to target early pathogen recognition. The prevailing theory of why PJIs become 
chronic and difficult to treat is the devastation to the localized environment overcomes the immune 
system’s ability to combat the infection, so it is critical to dissect the specific influences of PJIs on 
surrounding tissues. The effects of chronic PJI on localized tissues have recently become of interest 
for researchers in the field of Orthopaedics [58-60]. 
 
Studying the specific deviations in immune signaling could lead to the identification of 
tissue-level biomarkers of PJI relevant to treatment. Once chronic PJI is established, it is difficult 
to treat, but surgical strategies can manage the infection. The gold standard involves debridement 
and irrigation of the wound area to remove infected tissues, either decreasing the bacterial load to 
a level the immune system can overcome or completely removing the infected tissues. While this 
strategy shows the highest rates of success in persistent PJI, it is expensive and often requires 
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additional surgical intervention [52]. Further, debridement is a subjective technique in which the 
surgeon is tasked with visually inspecting the tissue to determine viability. While Orthopaedic 
surgeons undergo extensive training, it can be challenging to eradicate infected tissue using only 
visual inspection. Even a small number of bacteria remaining (i.e., a few colonies) can lead to re-
infection of the joint [61]. Failure rates of procedures can reach as high as 50% in infected joints, 
partly because subjective measures of debridement are not sufficient [62]. Delineating healthy and 
infected tissues in PJI is critical, but no tissue-level biomarkers are established for intra-operative 
assessment to inform treatment.  
 
Several biomarkers have been identified for their diagnostic utility in PJI but have not been 
investigated for their ability to identify healthy versus infected tissues. While serum and synovial 
fluid measurements of cytokines like IL-1β, IL-6, IL-10, and IL-8 have been incorporated into 
clinical protocols for PJI diagnosis [63], they do not provide information about tissue viability. 
Establishing diagnostic biomarkers of infected tissues in PJI requires a high degree of sensitivity 
and specificity [64]. Sensitivity is a measure of how well the biomarker identifies true positives 
(e.g., how many tissues are correctly identified as infected; Equation 1.1). Low sensitivity can lead 
to a high number of false negatives, or type II error. Specificity describes how well the biomarker 
determines true negatives (e.g., how many healthy tissues can be identified as non-infected; 
Equation 1.2). Low specificity can lead to a high number of false positives, or type I error. In 
biomarker development, there is a balance between sensitivity and specificity, with higher 











𝑇𝑟𝑢𝑒 𝑁𝑒𝑔𝑎𝑡𝑖𝑣𝑒𝑠 + 𝐹𝑎𝑙𝑠𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
 (1.2) 
 
Biomarker analysis through enzyme-linked immunosorbent assays (ELISAs) is an 
attractive analytical technique to investigate targets related to tissue health in PJI. Due to the 
complexity of the inflammatory environment, it would likely be advantageous to study a suite of 
immune-related targets and the healing cascades associated with tissue damage in chronic infection 
and inflammation. Many immune and healing mediators exhibit low homeostatic concentrations 
in blood or localized fluids (e.g., picomolar) [65, 66], but stimulation by inflammatory stressors 
like infection can cause increases of up to 1,000-fold [67]. Cost-effective, high throughput 
multiplexed ELISAs offer a solution to investigate multiple targets related to immune and healing 
processes simultaneously. Multiplexed assays use multiple antibodies immobilized to the surface 
of a polystyrene bead, and measurements are made using a dual-laser flow cytometric system [68]. 
Multiple detection antibodies are used, and dyes correspond to the analyte of interest, and up to 
100 different antibody-antigen combinations can be included per bead [69]. A classification laser 
identifies the unique signature of each analyte region, and a reporter laser measures the 
fluorescence intensity of the signal (Figure 1.5). The accuracy of this method is dependent on CV, 
upper and lower limits of quantitation [70], and quality of the calibration curve but has shown 




Figure 1. 5. Bead-based ELISA. Microsphere beads have multiple antibodies immobilized to the 
surface, corresponding to different antigens. A two-laser system consists of: (1) one detection to 
measure emission of dye specific to each analyte, and (2) another detection to measure the emission 
of Streptavidin-PE (or similar fluorophore) to measure the fluorescence intensity and quantify each 
analyte. The multiplexed assay format proceeds similar to a traditional sandwich ELISA, but many 
capture antibodies are immobilized on the surface. The biotinylated detection antibody shown in 
blue recognizes a separate epitope of your desired analyte. The biotinylated detection antibody 
then binds with the fluorescent reporter, streptavidin-phycoerythrin (shown in green), due to the 
extremely high binding affinity of biotin for streptavidin. This image was modified with 
permission from Vrana 2015 [72]. 
 
1.3.2 Dysregulation of cell signaling in other conditions 
Disrupted cell signaling processes are common in many other conditions, such as 
autoimmune disorders, cancer, and Alzheimer’s Disease, and investigating signaling networks has 
led to advances in diagnostics and therapeutics for these pathologies. Here, a few examples are 
discussed to highlight the potential for similar research to provide insight for chronic infections 




Cytokines IL-4 and IL-13 are potent initiators of allergic response, and the IL-4/IL-
13/STAT6 pathway is central to asthma modulating [73]. Elevation of these factors has been 
observed in inflammatory airways of asthmatics, and some asthma drugs target IL-4/IL-13/STAT6 
to suppress the inflammatory response. Targeting cell signaling pathways in asthma has not only 
led to better drug targets, but differential network analysis has also revealed disparate hub genes 
associated with inflammation, apoptosis, and T cell activity for allergic responses [74]. Networks 
associated with various cancers have also been probed to identify new therapeutic targets. Many 
cancers involve disrupted cell signaling, especially processes related to proliferation and survival. 
Novel therapies for hepatocellular carcinoma have been reached through targeting of 
Ras/Raf/MAPK [75], PI3K/AKT/mTOR [76], Wnt/β-catenin [77], and hedgehog signaling 
pathways [78], four highly evolutionarily conserved pathways relevant to a number of critical 
cellular processes. Recently, studies of Alzheimer’s Disease illustrated that new immune-related 
targets HLA-B, IL-10, C1QB, and CD86 could be pursued to prevent disease and that disease 
etiology of Alzheimer’s showed similarities to antigen presentation through network analysis [79]. 
Dissecting the complex signaling pathways in these conditions provided a better understanding of 
the alterations to normal cell signaling provoked by disease states. These represent a few of the 
many examples to illustrate the utility of investigating signal transduction networks in disease.  
 
 Bioinformatics approaches to understand complex biological responses 
Biomarkers for diagnosis and treatment have been elucidated for many diseases, from 
infection to autoimmune inflammatory disorders to cancer and beyond, and researchers employ 
different statistical approaches and methodologies to understand these complex responses. It is 
often advantageous to approach these using network analysis rather than traditional statistical 
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testing like t-tests and ANOVAs, and studying chronic infection like PJI through network analysis 
may provide a better understanding of the complex inflammatory environment. Network analysis 
approaches can involve the integration of different data types and allow researchers to investigate 
interactions of different targets involved (i.e., transcripts, proteins, metabolites) [80]. These 
approaches have expanded on classical statistical techniques to probe beyond the investigation of 
a single molecular entity. Recent accessibility of multi-‘omics technologies have made network-
wide assessments more common when studying disease states, and new multi-‘omics studies of 
disease have led to the discovery of biomarkers with higher specificity than those identified in 
classical statistical testing (e.g., ANOVA, t-test, ROC), and this may be due to the ability to 
consider the entire network as a whole rather than analyzing each target in isolation [81]. Database 
searching software applications and mathematical modeling techniques have been utilized in a 
variety of diseases to understand underlying molecular patterns of disease etiology.  
 
1.4.1 Background on common network methodologies 
Biological network analysis is central to understanding complex biological processes, and 
recent technologies have shifted research towards large-scale biological datasets that measure 
many parameters. Multi-‘omics studies (e.g., transcriptomics, genomics, proteomics, 
metabolomics, interactomics) are the primary ways researchers approach network studies, 
covering every portion of the journey from DNA to protein to protein-protein interactions in 
signaling [82-84]. Ultimately, studying biological responses through these various platforms 
allows a holistic view of cells and tissues to identify which targets are most important for survival 
or death. High-throughput technologies like next-generation sequencing, microarrays, and hybrid 
screening to identify interactions of biological network components have made it possible to 
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collect a large amount of data with relative ease and allowed exponential growth of network 
repositories and databases to aid in the analysis of cellular network data. Cutting-edge mass 
spectrometry techniques allow for global assessment of proteins, metabolites, and other species of 
interest in biological samples [85]. The advent of multi-‘omics approaches has paved an exciting 
path forward, allowing for a more complete understanding of complex biological interactions. 
These technologies can be applied for biomarker identification [86], drug discovery [87], and in 
the future of personalized medicine [88]. 
 
Researchers that take advantage of these techniques produce hearty data sets with large 
amounts of information, but this presents a problem of its own: what is the best way to analyze, 
integrate, and interpret the data? Biological networks and interactions of proteins within the 
network can be constructed from literature-derived and experimental data. Additionally, data can 
be acquired in many forms, including protein-protein interactions, protein function prediction, 
association with canonical networks, and more. Some commonly-used network methodologies are 
based on graph theory, Bayesian approaches, and correlations to draw connections between 
individual targets to form a network [81]. These approaches can be used to answer a wide range 
of biological questions concerning genetic causes of disease, target identification for biomarkers 
of drug discovery, and monitoring of treatment [89].  
 
1.4.2 Databases and model repositories 
Databases and repositories are commonly used in biological network analysis, and they often 
take both literature-derived data and the researcher’s experimental data into account. Many 
databases exist primarily to analyze network data, and the researcher must consider the nature of 
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the data, application, and interpretation when deciding which database(s) to utilize. Model 
organisms, tissue types, and diseases may also be considered; databases and model repositories 
are carefully curated, but some may be more appropriate for different etiologies [90]. These 
network-based studies are often carried out in model organisms, including both in vitro and in vivo 
research. These are considerations when choosing which database(s) to use and what caveats must 
be acknowledged when interpreting the data. Some examples include the Reactome Pathway 
Knowledge Base [91], KEGG genome database [92], Gene Ontology (GO) GOnet [93], Ingenuity 
Pathway Analysis (IPA) [94], and Cytoscape [95]. Most of these tools rely on basic statistical tests 
to identify significant targets. Reactome uses a simple binomial test to calculate significant 
deviations from expected observations and create links between different entities. KEGG and GO 
use hypergeometric probabilities to enrich data sets by identifying associations with individual 
nodes of interest. IPA connects individual targets through Fisher’s Exact Test to construct a 
network of biological nodes. Some tools, like Cytoscape, allow the user to have more control over 
the tests for significance, which provides more flexibility when working with different types of 
data. Databases differ in analysis methods, so researchers must thoroughly understand what 
information the database can provide and its limitations. Some common databases and repositories 
used to interpret biological networks are discussed in the following paragraphs. 
 
Systems biology approaches have centered around network analysis, and these techniques 
have demonstrated broad utility in addressing questions of disease etiology to therapeutics, making 
them extremely attractive to researchers. Studies cover a wide range of data types, collection 
methods, statistical analysis approaches, and aims, demonstrating the highly diverse studies that 
benefit from network analysis techniques. Network analysis using databases and repositories have 
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led to better targets for cancer therapeutics [96], a better understanding of the immune response to 
asthma [97], and biomarkers of disease progression in Amyotrophic Lateral Sclerosis (ALS) [98], 
to name a few of the many pathological states that have been investigated. While it is often 
advantageous to use network approaches, problems can arise due to insufficiencies in data related 
to a particular model organism, the number of relevant studies in the database for a specific disease, 
and lack of spatial and temporal information (i.e., mismatches in time points or distance from 
injury) [89]. Progress in data analysis in the future will depend on broadening the model organisms 
and scopes of disease, including the inclusion of multiple ‘omics platforms for diseases. The more 
data within the repositories these databases use, the more accurate the machine learning algorithms 
can become, ultimately providing better answers to systems biology questions. Network 
approaches have expanded the knowledge of biological systems and have proven to be an essential 
asset for the future of signal transduction research.     
 
1.4.3 Advanced mathematical network analysis approaches 
The use of biological network applications to analyze a dataset is highly beneficial for 
many researchers, especially in disease states that have been well studied. Challenges can arise 
when investigating diseases that have not been well characterized and only have a small number 
of studies relevant to signal transduction mediators. For these cases, advanced statistical 
techniques like mathematical modeling offer an alternative, as they rely solely on the parameters 
the investigator includes. Network centrality is one approach, and it is based upon graph theory, 
which mathematically organizes the different parameters to create a “map” of their interactions 
and interconnectivity [99]. In graph theoretical analysis, the network consists of nodes and edges. 
Nodes are parameters within the network (i.e., proteins, genes, metabolites), and edges represent 
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the interactions of node pairs. Using graph theory, researchers can characterize the biological 
network by connecting nodes and assigning quantitative values to their influence on the network 
as a whole. A common approach for interpretation of these networks is to analyze through a lens 
of network centrality, as this can properly weight the interactions of the network, providing 
information on highly interconnected nodes vs. peripheral nodes, which can then be interpreted 
for their biological roles [100].  
 
Many other advanced mathematical modeling and statistical techniques have been 
employed to analyze networks, including principal component analysis (PCA), partial least squares 
discriminant analysis (PLS-DA), and hierarchical clustering [101]. These techniques reduce the 
dimensions of the dataset and combine parameters to model the system, thereby significantly 
reducing the complexity and allowing interpretation. Predictive modeling can be integrated into 
these techniques to evaluate the model’s ability to accurately group proteins, genes, etc., to 
describe an altered biological state. New tools that utilize advanced statistical principles to dissect 
large biological network data are being developed in the field, and many of them are based upon 
these techniques. For example, new statistical strategies have been employed to integrate multi-
‘omics data based on orthogonal PLS approaches, illustrating the potential to narrow variables of 
interest [102]. The probabilistic modeling technique ProbRules was developed to predict the 
behavior of dynamic signaling networks based on differential equations, allowing the ability to 
focus wet-lab experiments a priori [103]. Williams et al. developed a “functional heatmap” to 
quickly assess time-series multi-‘omics data based on cluster analysis, providing the means to 
quickly assess patterns in large data sets [104]. These represent only a few examples of the 
possibilities of new tools developed to support signal transduction research. At their cores, 
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traditional multivariate statistical approaches laid the foundation for these tools and allowed 
researchers to expand their use to handle multi-‘omics data sets. 
 
Choosing which mathematical technique is appropriate for a data set is dependent on the 
format of the data, desired outcomes, and goals of the research. All of the described analysis 
methods have been proven in the literature to manage large, complex biological datasets, and 
researchers are developing new techniques to integrate multi-‘omics data sets for their own 
purposes. As multi-‘omics techniques become more widely adopted for studies of biological 
networks, network analysis through database searching, mathematical modeling, and repositories 
highlight a new frontier to dissect complex biological milieu to understand diseases like chronic 
infection. 
 
The work presented in the following chapters describes comparisons of immune-related 
cytokines and wound healing phosphoproteins in response to implants and infection in order to 
understand cell signaling changes in response to these stimuli. Based on previous work to 
understand cytokine responses in PJI on a serum level [52, 53], the prevailing hypothesis was that 
higher concentrations of cytokines would be present in septic tissues, and these could be developed 
into tissue-level biomarkers of infection. Phosphoproteins related to wound healing processes were 
also tested to probe the interactions between inflammatory immune cytokines and tissue healing 
mediators. The purpose of this work was to provide a novel tissue-level investigation to provide 
new insights into changes related to implants and chronic infection. 
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2. Localized Cytokine Responses to Total Knee Arthroplasty and Total Knee Revision 
Complications1 
 The study of localized immune-related factors has proven beneficial for a variety of 
conditions, and one area of interest in the field of orthopaedics is the impact of implants and 
localized infections on immune response. Several cytokines have shown increased systemic 
concentrations in serum/plasma due to implants and infection, but tissue-level cytokines have not 
been investigated as thoroughly. This exploratory study investigated tissue-level cytokines in a 
cohort of patients (N=17) in response to total knee arthroplasty and total knee revision to better 
understand the immune response to implants and localized infection (e.g., prosthetic joint 
infection). The overall goal of this study was to provide insight into the localized cytokine response 
of tissues and identify tissue-level markers specific to inflammation caused by implants versus 
inflammation caused by infection. Tissues were collected across several anatomical locations and 
assayed with a panel of twenty human inflammatory cytokines to understand spatial differences in 
cytokine levels. In this study, six cytokines were elevated in implanted joints, as compared to 
native joints: IL-10, IL-12p70, IL-13, IL-17A, IL-4, and TNF-α (p<0.05). Seven cytokines showed 
infection-dependent increases in localized tissues: IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, and 
MIP-1β (p<0.05). This study demonstrated that differences exist in tissue-level cytokines in 
response to presence of implant, and some cytokines were specifically elevated for infection; these 
responses may be informative of overall tissue health. These results highlight the utility of 
investigating localized cytokine concentrations to offer novel insights for total knee arthroplasty 
and total knee revision procedures, as well as their complications. Ultimately, this information 
 
1 Parts of this chapter have been published previously from Prince N, Penatzer JA, Dietz, MJ, and Boyd, JW. 
Localized Cytokine Responses to Total Knee Arthroplasty and Total Knee Revision Complications. Journal of 
Translational Medicine. 18, 330 (2020). 
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could provide additional, quantitative measurements of tissue to aid clinical decision making and 
patient treatment options. 
 Introduction 
 The inflammatory response to infection involves a series of biological events regulated by 
a number of immune mediators, and the actions of these immune factors are partially reliant on 
the cytokines and chemokines produced in response to pathogens, foreign bodies, and other stimuli 
[1-3]. These responses are of interest to the field of orthopaedics, especially with regard to the 
immune response to implants, infection, and chronic inflammation [4-6]. An elevated immune 
response has been observed following total knee arthroplasty (TKA) procedures, and increased 
levels of cytokines, particularly interleukin (IL)-1, IL-4, IL-6, IL-10, and tumor necrosis factor 
alpha (TNF-α), have been observed on a systemic level (i.e., serum/plasma) as well as on a more 
localized level (i.e., synovial fluid) [7-9]. However, many aspects of this response are not well 
understood, so the inflammatory response in orthpaedic implants and implant infections remain 
uncharacterized. A majority of TKA procedures are successful, but implant-related and infection-
related complications can negatively affect a patient’s quality of life. Properly addressing these 
issues is of high priority to the field of orthopaedics, especially considering the increasing demand 
for joint replacement [10].  Many studies have noted the pain, inflammation, and dissatisfaction 
that can occur following these procedures, affecting approximately 20% of patients undergoing 
TKA [11, 12], but it is not entirely known what role cytokines play in this chronic inflammatory 
response. 
 
Infections, such as prosthetic joint infection (PJI), are serious complications and the source 
of excessive joint inflammation, leading to higher rates of total joint failure [13]. PJI is a localized 
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infection surrounding a prosthetic joint and can result following implantation, often necessitating 
surgical intervention [14]. PJI is a major concern following TKA/total knee revision (TKR) 
procedures and can be difficult to treat. The infections are often persistent and unable to be 
resolved using conventional methods, presenting a challenge for clinicians [15]. The systemic 
immune response to PJI has been studied extensively, but the localized tissue response is not as 
well understood. In order to better understand the immune response to implants and localized 
infection, this study investigated levels of twenty inflammatory cytokines in localized tissue 
surrounding the joint. While defining the localized response to implants and infection can be 
difficult [7-9], localized cytokine responses have been investigated for other pathological 
conditions. A few studies have characterized localized cytokine responses in trauma [16-18] and 
respiratory infection [19], and these studies demonstrated that the local cytokine environment 
differs when compared to systemically circulating levels. Currie et al. showed that differences in 
cytokine concentrations exist in skeletal muscle samples in a spatially-dependent manner using an 
animal model of traumatic injury [16]. Similarly, Hauser et al. observed differences in levels of 
cytokines at the site of injury compared to systemic levels in response to trauma in humans [18]. 
Other research groups have observed spatially-related differences of other immune-related factors 
for stroke [20], and in response to allergens [21] in animal models. These studies introduced the 
concept of using immune markers on a localized level to better understand these conditions.  
 
TKA and TKR procedures trigger inflammatory cascades, initiating cytokine responses 
and elevating systemic cytokine concentrations; higher levels of cytokines have been observed 
following these surgeries. The elevation in cytokine levels has been attributed to the trauma of 
surgery as well as the introduction of implants into the body [22, 23]. However, this inflammation 
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is sometimes prolonged, which can cause major complications for patients. The causes of chronic 
inflammation following these procedures are still unknown, and resolution of the inflammation is 
challenging [24]. Therefore, understanding the changes in inflammatory response specific to 
implant-related inflammation is beneficial to improving the outcome of these individuals.  
 
Tissue-level response to PJI has not been characterized to understand the local immune 
modulation in these cases. Many studies have investigated systemically circulating levels of 
interleukins and other cytokines for their roles in infection, and several cytokines are used as 
diagnostics of PJI [25-27]. Several studies have specifically focused on the utility of measuring 
IL-6 and IL-8 levels in serum for diagnosing and monitoring PJI, both of which have increased 
specificity over conventional methods; this knowledge has greatly benefitted the clinical treatment 
options for PJI [28, 29]. However, PJI remains one of the most serious complications following 
revision knee arthroplasty. In fact, infection is one of the most common causes for revision, being 
implicated in 20.4% of all revision TKA procedures between 2009 and 2013 [30]. While defining 
the systemic response to sepsis and infection has paved the way for improved diagnostics [31-33], 
less is known about the environment of localized infections and what role cytokines play in 
determining tissue health.  
 
The present study focused on understanding differences in localized distributions of 
cytokines in TKA and TKR procedures, with and without presence of infection, using PJI as the 
model for localized infections. The ultimate goal of this study was to characterize the immune 
modulation on a tissue level that occurs in response to joint implantation and infection to better 
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understand localized tissue health. The information gained could aid clinical management of these 
complications by narrowing down cytokines that are indicative of response to PJI. It represents the 
first known investigation of tissue-level cytokines in response to implant-related and infection-
related complications, to our knowledge. 
 
 Materials and methods 
2.2.1 Patient cohort 
Following Institutional Review Board (IRB) approval (IRB Protocol #1709745853) and 
patient consent, six patients undergoing primary total knee arthroplasty (TKA) and eleven patients 
undergoing total knee revision (TKR) procedures participated in the study (8 males, 9 females; 
aged 45-82 years; body max index [BMI] 24.6-43.7). Subjects were recruited over a 12-month 
period. All six primary TKA patients were undergoing elective surgery for total replacement of 
the knee joint with a diagnosis of osteoarthritis. At the time of this study, this was the first 
arthroplasty procedure on either knee joint. In the TKR group, patients were further characterized 
into aseptic and septic revision procedures. Patients with aseptic revisions (N=5) were undergoing 
revisions due to failures of the prosthetic joint but did not show presence of infection. For ease of 
the reader, samples from these patients will be referred to as aseptic TKR tissues. Patients with 
septic revisions (N=6) met clinical criteria for a PJI diagnosis as defined by the Musculoskeletal 
Infection Society (MSIS) criteria [13]. Samples from these patients will be referred to as septic 
TKR tissues. All six patients diagnosed with PJI were tissue culture positive: four tested culture 
positive for Staphylococcus epidermidis, one for Methicillin-sensitive Staphylococcus aureus 
(MSSA), and one for Enterobacter cloacae. More patient information can be found in Table 2.1 
below. Systemic C-reactive protein (CRP) levels in serum are additionally listed as reference. 
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Table 2. 1. Patient Information. Six primary TKA and eleven revision TKR patients were enrolled 
in the study, creating a heterogenous cohort of males and females varying in age (45-82 years) and 
comorbidities. Primary TKA patients have ID format P#; revision TKR patients have ID format 
F#. This table lists general patient information including the pathogen for which each septic patient 
tested culture-positive following testing on the day of surgery. Serum CRP values were obtained 
pre-operatively in the revision setting. Cultures were obtained from intraoperative tissue samples.   
 
ID Sex TKA/TKR BMI(kg/m2) Diabetic (Y/N) CRP (mg/L) Culture 
P1 F TKA 33.8 N N/A Negative 
P2 F TKA 39.8 N N/A Negative 
P3 F TKA 39.8 N N/A Negative 
P4 M TKA 29.7 Y N/A Negative 
P5 M TKA 24.6 N N/A Negative 
P6 M TKA 27.2 N N/A Negative 
F1 F TKR- Aseptic 28.2 N 4.3 Negative 
F2 F TKR- Aseptic 29.8 N 0.2 Negative 
F3 F TKR- Aseptic 33.9 N <1 Negative 
F4 M TKR- Aseptic 40.4 Y 3.6 Negative 
F5 M TKR- Aseptic 26.2 N 2.1 Negative 
F6 F TKR- Septic 43.7 N 28.8 S. epidermidis 
F7 F TKR- Septic 30.8 Y 161.4 S. epidermidis 
F8 F TKR- Septic 41.9 N 21.7 E. cloaecae 
F9 M TKR- Septic 36.2 N 33.5 MSSA 
F10 M TKR- Septic 33.8 Y 3.8 S. epidermidis 




2.2.2 Collection of tissue samples 
All TKA and TKR procedures were performed by a single surgeon with standard 
debridement and washing protocols. Tissues were collected at a total of four distinct anatomical 
locations, broadly characterized into two tissue layers: four adjacent tissue layer (ATL) samples 
and three radial tissue layer (RTL) samples. The ATL samples came from the initial debridement. 
Tissues from the ATL layer were closer to the knee joint (or prosthetic implant). Conversely, RTL 
samples were taken from a tissue layer further removed from the joint (or prosthetic implant) after 
the surgeon completed debridement. The difference in depth of the RTL tissues and ATL tissues 
was approximately 5-10 mm and was dependent on the individual patient. Measurements were 
made from point of origin to standardize tissue samples taken between patients. Tissues were taken 
at four anatomical locations illustrated in Figure 2.1. Briefly, the solid line circle represents 
location 1) medial femoral condyle (F); the dashed line circle represents location 2) medial tibial 
plateau (T); the solid line square represents location 3) lateral gutter (LG); and the dashed line 
square represents location 4) posterior capsule (PC). Anatomical locations 1-4 were collected for 
the ATL layer, and locations 1-3 were collected for the RTL layer. Location 4, PC, could not be 
taken in the RTL layer due to proximity to neurovascular structures. Therefore, a total of seven 
















Figure 2. 1. Map of approximate tissue collection locations, shown with prosthetic implant 
illustrated. Seven tissue samples were taken for each patient; 1) the solid circle represents the 
medial femoral condyle (denoted as F); 2) the dashed circle represents the medial tibial plateau 
(denoted as T); 3) the solid square represents the lateral gutter (denoted as LG); 4) the dashed 
square represents the posterior capsule (denoted as PC). Locations 1-4 were taken for the ATL 
layer, and locations 1-3 were taken for the RTL layer; separation between ATL (closer to joint) 
and RTL (further from joint) was approximately 5-10 mm, depending on individual patient. 
 
2.2.3 Sample preparation 
Tissues were collected during TKA and TKR procedures in the operating room and 
immediately stored on dry ice. Once all tissues had been collected for an individual patient, they 
were washed with 1X cold phosphate-buffered saline (PBS) to remove blood and debris. Tissues 
were grossly dissected using a scalpel to remove scar tissue or cement, then stored at -80 ºC. When 
samples had been collected for all patients, tissues were thawed on ice and cut into sections 







(Bio-Rad, Hercules, CA) containing 20 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich, St. 
Louis, MO). Protein extraction was performed using methods adapted from Hulse et al. [34]. 
Thawed samples were vortexed for 1-3 s and centrifuged at 5,000 x g for 5 minutes at 4 °C. The 
supernatant was collected and tested for total protein content using a Pierce BCA Protein Assay 
Kit (Thermo Scientific, Waltham, MA), according to manufacturer’s instructions. Absorbance 
values for total protein content were determined on an Infinite M1000 multimode plate reader 
(Tecan, Raleigh, NC). 
 
2.2.4 Cytokine measurement 
To standardize samples for total protein content, tissue homogenates were individually 
diluted to a total protein concentration of 900 µg/mL with cell lysis buffer (Bio-Rad). Cytokine 
quantification was performed using a magnetic bead-based multiplex Inflammation Human 
ProcartaPlex panel assay (Invitrogen, Carlsbad, CA) and measured using a Bio-Plex 200 
suspension array system and Pro II Wash Station (Bio-Rad), according to the manufacturer’s 
instructions. Cytokine concentrations were averaged to represent values for the ATL and RTL. 
Four tissues were averaged to calculate ATL average (LG, F, T, PC), and three tissues were 
averaged to calculate RTL average (LG, F, T). A table of cytokine values at ATL and RTL and 
graphs of cytokine concentrations at individual tissue locations are available in Appendix A. 
 
2.2.5 Statistical analysis 
Data were analyzed using Prism 5 (GraphPad, San Diego, CA) and SAS JMP (Cary, NC). 
Standard curves were generated for each protein using either a four- (4PL) or five-parameter 
logistic (5PL) regression model, depending on the individual protein. Cytokine concentrations 
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were determined using standard curve interpolation, then corrected by dilution factor to compare 
tissue homogenates. Cytokine concentrations are expressed as picograms of cytokine per milliliter 
of tissue homogenate (pg/mL). Samples with fluorescence intensity values below the lower limit 
of quantitation (LLOQ) or above the upper limit of quantitation (ULOQ) were omitted from 
statistical comparisons. Outliers were identified using the 1.5 X interquartile range (IQR) rule and 
omitted from analysis. Two-way analysis of variance (ANOVA) with Bonferroni’s post-test was 
used to determine significant differences between primary TKA, aseptic TKR, and septic TKR 
tissue samples at each tissue location. Each tissue homogenate was tested in duplicate for cytokine 
concentration. Data are expressed as the mean ± standard error of the mean (SEM). 
 
Quadratic discriminant analysis was conducted to evaluate the combined capacity of 
cytokine response to predict the state of tissue. Using SAS JMP, all measured responses were cast 
as covariates, and the “group” was assigned as a classification category (primary TKA, aseptic 
TKR, septic TKR). The Shrink Covariances option was applied to account for the different 
covariances within the categories. Quadratic discriminant analysis is a predictive modeling tool, 
and when there are a large number of variables compared to observations, as is the case in this 
study, Shrink Covariances is frequently employed to improve the stability and reduce prediction 
variance [35]. This analysis included 13 covariates; only those cytokines that produced statistically 
significant two-way ANOVA comparisons for either infection-specific or implant-specific 
comparisons were included: IL-1α, IL-1β, IL-6, IL-8, monocyte chemoattractant protein (MCP)-
1, macrophage inflammatory protein (MIP)-1α, MIP-1β, IL-10, IL-12p70, IL-13, IL-17A, and 
TNF-α. Biplot rays are plotted to indicate how each covariate influences the canonical space, with 
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the direction and magnitude signifying the degree of association with the respective group (primary 
TKA, aseptic TKR, septic TKR). 
 
Due to the limited sample size, this study was not able to control for age, sex, BMI, or other 
comorbidities. Pearson correlations were run between cytokine concentrations and age, sex, and 
BMI for each patient to analyze the contribution of these variables. Bonferroni’s correction was 
applied to correct for multiple inferences, as previously described by Bland et al. [36].  
 
 Results 
Changes in cytokine concentrations were observed for comparisons of primary TKA vs. 
aseptic TKR vs. septic TKR tissues. Overall, cytokine concentrations were generally elevated in 
TKR (both septic and aseptic) compared to TKA, and septic TKR exhibited higher cytokine levels 
than aseptic TKR for several cytokines. Seven cytokines (IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-
1α, and MIP-1β) showed increased concentrations in septic TKR tissues compared to both aseptic 
TKR tissues and primary TKA tissues (p<0.05). Six cytokines (IL-10, IL-12p70, IL-13, IL-17A, 
IL-4, and TNF-α) showed differences in concentration between primary TKA and TKR (both 
aseptic and septic) (p<0.05), but these six cytokines were not significantly different between 
aseptic TKR and septic TKR. These comparisons are described in detail over the following 
sections. Additional human inflammatory cytokines were tested, but they did not produce 
statistically significant comparisons at p<0.05 in this study: E-Selectin, granulocyte-macrophage 
colony-stimulating factor (GM-CSF), interferon-alpha (IFN-α), interferon-gamma (IFN-), and 
interferon gamma-induced protein 10 (IP-10).  
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2.3.1 Seven cytokines exhibited infection-specific elevations in concentration 
Seven cytokines showed an increase in concentration that was dependent on the presence 
of localized infection: IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, and MIP-1β (p<0.05). For these 
cytokines, primary TKA averages were lowest, with an increase in aseptic TKR and further 
increase in septic TKR. For IL-1α, the average concentration of primary TKA tissues was 
1.1 pg/mL, and rose to 11.8 pg/mL in aseptic TKR; the concentration was elevated to 30.3 pg/mL 
in septic TKR. Further, in the septic TKA group, there was a statistically significant difference 
between ATL and RTL averages (p<0.05). IL-1β showed a similar trend, with a mean of 1.7 pg/mL 
in primary TKA tissues, which rose to 5.4 pg/mL in aseptic TKR, and further elevated to 
39.1 pg/mL in septic TKR. IL-1β also reflected the spatial disparity in concentration between ATL 
and RTL in the septic TKR group (Fig. 2.2). IL-6 followed, with an average of 8.5 pg/mL in 
primary TKA, rising to 24.2 pg/mL in aseptic TKR, and finally 610.7 pg/mL in septic TKR. IL-8 
levels were 7.6 pg/mL in primary TKA, which increased to 91.1 pg/mL in aseptic TKR, and rose 
to 553.9 pg/mL in septic TKR. For MCP-1, the average of primary TKA tissues was 113.0 pg/mL, 
which increased to 258.8 pg/mL for aseptic TKR, and further increased to 565.1 pg/mL for septic 
TKR. MIP-1α followed the same trend, with an average of 7.8 pg/mL for primary TKA, which 
rose to 27.8 pg/mL in aseptic TKR, and was elevated to 81.6 pg/mL in septic TKR. ATL locations 
showed the most significant increases in MIP-1α between groups (Fig. 2.2, p<0.05). For MIP-1β, 
primary TKA tissues showed an average of 21.3 pg/mL and were increased to 46.0 pg/mL for 
aseptic TKR and further increased to 123.4 pg/mL in septic TKR. As shown in Figure 2.2, cytokine 
concentrations in the ATL layer locations were generally higher than the RTL layer locations for 






































































































































































































Figure 2. 2. Seven cytokines showed infection-dependent elevation in localized tissues. Average 
cytokine concentration for ATL and RTL are shown for all groups. Two-way ANOVAs with 
Bonferroni’s post-test were conducted to test for significant differences between groups at each 
tissue depth (p<0.05). Significant differences between groups at a particular location are marked 
as: P denotes significant difference from primary TKA (N=6); A denotes significant difference 
from aseptic TKR (N=5); S denotes significant difference from septic TKR (N=6); all symbols 
denote significance at the p<0.05 level. 
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2.3.2 Six cytokines exhibited implant-related elevations in concentration (Primary TKA 
vs. Aseptic/Septic TKR) 
Six cytokines, IL-10, IL-12p70, IL-13, IL-17A, IL-4, and TNF-α, exhibited higher levels 
in TKR tissues as compared to primary TKA tissues ( Fig. 2.3 p<0.05). In other words, there were 
significant differences (p<0.05) between primary TKA and aseptic/septic TKR, but there were no 
significant elevations in concentration from aseptic TKR to septic TKR. For IL-10, the average 
value in primary TKA was 0.9 pg/mL, 8.4 pg/mL in aseptic TKR, and 6.6 pg/mL in septic TKR. 
With the same general trend, IL-12p70 had an average of 5.7 pg/mL in primary TKA, 30.7 pg/mL 
in aseptic TKR, and 20.7 pg/mL in septic TKR. For IL-13, the average in primary TKA was 
1.8 pg/mL, 9.6 pg/mL in aseptic TKR, and 9.9 pg/mL in septic TKR. Following this trend, IL-17A 
average concentrations were 5.3 pg/mL in primary TKA, 16.3 pg/mL in aseptic TKR, and 
18.9 pg/mL in septic TKR. For IL-4, average concentration in primary TKA was 6.9 pg/mL, which 
rose to 19.6 pg/mL in aseptic TKR, and further to 24.8 pg/mL in septic TKR. Finally, TNF-α 
followed the same trend, with an average concentration of 16.9 pg/mL in primary TKA, 
71.1 pg/mL in aseptic TKR, and 86.8 pg/mL in septic TKR. None of these six cytokines showed 


















































































































































































Figure 2. 3. Six cytokines showed implant-related elevation in localized tissues that was not 
infection-dependent. Average cytokine concentrations for ATL and RTL are shown for all groups. 
Two-way ANOVAs with Bonferroni’s post-test were conducted to test for significant differences 
between groups at each tissue depth (p<0.05). Significant differences between groups at a 
particular location are marked as: P denotes significant difference from primary TKA (N=6); A 
denotes significant difference from aseptic TKR (N=5); S denotes significant difference from 




2.3.3 Quadratic discriminant analysis (QDA) cytokine profiles for TKA vs. TKR 
The two-way ANOVA comparisons of cytokines between different groups revealed seven 
cytokines that showed infection-specific elevation (beyond inflammation caused by implants), and 
six cytokines that showed increases due to implants, but not infection (Figures 2.2 and 2.3). To 
further probe the structure of these cytokine profiles between groups, quadratic discriminant 
analysis was conducted. These thirteen cytokines were included as covariates. The analysis 
classified the combined observed responses into pre-determined groups of primary TKA, aseptic 
TKR, and septic TKR. The group was predicted based on the covariate responses associated with 
each group, respectively. For each group, all seven locations were included for all individuals in 
that group, which means there were 42 counts for primary TKA (7 tissue locations, 6 patients), 35 
values for aseptic TKR (7 tissue locations, 5 patients), and 42 counts for septic TKR (7 tissue 
locations, 6 patients). In total, of 119 counts, only 8 were misclassified, indicating a good 
prediction ability of the model. All 8 misclassifications were errors of a prediction of aseptic TKR 
group, when the values were originally from the septic TKR group. In other words, these 
individuals were falsely classified as aseptic based on cytokine profiles while they were actually 
septic. Further, there is overlap between the 95% confidence intervals for cytokine profiles of 










Figure 2. 4. Quadratic discriminant analysis (QDA) revealed distinct groupings for primary TKA 
vs. TKR (aseptic or septic). Cytokines with significant infection-dependent or implant-related 
elevations via two-way ANOVA were analyzed via quadratic discriminant analysis. Canonical 
scores for each cytokine (covariate) were calculated, and the 95% confidence interval is shown for 
primary TKA (green), aseptic TKR (red), and septic TKR (blue). The + symbol represents the 






2.3.4 Effects of age, sex, and BMI on cytokine concentrations 
The research presented here did not control for age, sex, or BMI due to the limited sample 
size of this exploratory study. To better understand the connections between cytokines of interest 
(IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, MIP-1β, IFN-γ, IL-10, IL-13, IL-17A, IL-4, and TNF-
α) and these factors, Pearson correlations were run and analyzed for statistical significance. When 
the Bonferroni’s correction was applied, as described in [36], none of the correlations between 
cytokine levels and age, sex, or BMI were significant (p>0.05), but the correlations are displayed 
in Table 2.2 for transparency. Although there is an established connection in the literature between 
inflammatory cytokine levels and age, sex, and BMI, the lack of significant Pearson correlation p-













Table 2. 2. Pairwise Pearson Correlation Values Between Cytokine Concentrations and Age, Sex, 
and BMI. The pairwise correlation values are listed for each of the three groups: primary TKA, 
aseptic TKR, and septic TKR. Pearson correlation values are rounded to two decimal places. No 
correlations were found to be significant at the p<0.05 level after Bonferroni’s correction. 
 
 Primary TKA Aseptic TKR Septic TKR 
Cytokine Age Sex BMI Age Sex BMI Age Sex BMI 
IL-1α 0.00 0.47 0.28 0.20 0.22 -0.54 -0.15 0.25 -0.05 
IL-1β -0.19 -0.06 -0.04 -0.30 -0.30 0.08 0.03 0.26 0.05 
IL-6 0.00 -0.09 -0.12 0.03 -0.19 -0.21 0.00 0.22 -0.02 
IL-8 0.03 0.59 0.25 0.06 -0.07 -0.32 -0.13 0.14 -0.14 
MCP-1 0.04 0.13 0.14 -0.18 -0.44 0.45 -0.07 0.20 -0.15 
MIP-1α -0.10 0.13 -0.04 -0.05 -0.30 0.09 0.33 0.08 -0.13 
MIP-1β -0.04 0.19 0.03 0.23 -0.06 -0.38 0.21 0.13 -0.16 
IL-10 -0.26 0.29 0.17 -0.31 0.00 -0.20 -0.11 -0.25 0.30 
IL-12p70 -0.06 0.02 0.03 -0.03 0.49 -0.32 -0.30 -0.18 0.33 
IL-13 -0.19 0.49 0.28 -0.06 0.41 -0.06 -0.22 -0.23 0.22 
IL-17A 0.00 -0.08 -0.31 0.31 0.85 -0.45 -0.34 0.06 0.32 
IL-4 -0.32 0.20 0.29 0.34 0.35 -0.55 0.21 0.02 -0.11 











Understanding inflammation in response to implants and infection following TKA and 
TKR procedures is a high priority for clinicians, as excessive inflammation can cause serious 
problems for patients. However, not much is known about the local immune response in these 
complex environments. While a variety of cytokines have been researched from a systemic view 
[40, 41], their clinical use is still debated [31-33, 42], and the cytokine responses have not been as 
well characterized on a localized tissue level. The tissue-level cytokine response may add further 
understanding of the localized environment and give insight into tissue health to aid clinicians in 
the management of these post-surgical complications. Tissue-level cytokines have been measured 
with respect to spatial gradients in traumatic injury [16-18], respiratory infection [19], stroke [20], 
and allergic response [21], and these studies provided useful information regarding the respective 
immune responses. These have established a basis for this study to investigate the use of cytokines 
to enlighten tissue viability following localized implant-related and infection-specific 
inflammation. 
 
This study focused on defining the tissue-level cytokine response to implants and infection 
across several anatomical locations. Many human inflammatory cytokines have been implicated 
in the systemic response to implants (i.e., in serum/plasma) [43-45] and now aid in diagnosis of 
infection [46, 47]. However, this investigation is the first, to our knowledge, to assess multiple 
tissue locations surrounding the joint to address implant-related vs. infection-specific responses. 
Seven cytokines were identified as infection-specific, showing elevated concentrations in the 
septic TKR cohort compared to both the aseptic TKR and primary TKA cohorts: IL-1α, IL-1β, IL-
6, IL-8, MCP-1, MIP-1α, and MIP-1β (p<0.05). Several of these cytokines have demonstrated 
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utility in previous studies for diagnosis of PJI (i.e., IL-1α, IL-1β, IL-6, IL-8), but this is the first 
instance of their investigation for tissue health and debridement [30-33]. Generally, these seven 
cytokines were elevated in the ATL depth compared to RTL, which brings to light the importance 
of proximity to joint in dictating cytokine response. Pro-inflammatory cytokines like IL-1α, IL-1β, 
IL-6, and IL-8 have been noted for their roles in early infection response, producing a warning 
signal of pathogen invasion, and this response was present in septic TKR tissues [48, 49]. These 
early cytokine indicators recruit factors like MCP-1, MIP-1a, and MIP-1b that propagate the 
response to pathogens through Th1 and Th2 immune signaling cascades [50, 51]. IL-1α and IL-1β 
in particular showed a statistically significant elevation in the ATL of the septic TKR group 
compared to the RTL of the septic TKR group, which suggested that these cytokines may be 
capable of distinguishing healthy and unhealthy tissue in PJI.   
 
Six cytokines were showed implant-related increases in concentration, with elevations in 
aseptic and septic TKR vs. primary TKA: IL-10, IL-12p70, IL-13, IL-17A, IL-4, and TNF-α 
(p<0.05). The elevated concentrations of these cytokines highlighted the degree of inflammation 
in implanted joints without the presence of infection, which is likely due to the presence of a 
foreign body. The implant-related inflammation reflected less of the macrophage activation 
present in the septic TKR group but exhibited elevation in anti-inflammatory cytokines like IL-10, 
IL-4, and IL-13 frequently associated with bone healing [7]. IL-17A and IL-12p70 have both pro- 
and anti-inflammatory roles, but the specific contributions to foreign body response are not well 
understood. Increased levels of these cytokines, as well as TNF-α, implies there may be 
dysregulation of inflammatory response due to implant. These cytokines were not significantly 
different in the septic TKR group compared to aseptic TKR at the p<0.05 level, so they may be 
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considered as indicators of aseptic or chronic inflammation that could be addressed with future 
research associated with TKA. The QDA analysis illustrated that cytokine profiles are distinct 
between all three cohorts, but there is significant overlap in the 95% confidence intervals of aseptic 
TKR and septic TKR. While there are several cytokines that distinctly separate these two cohorts, 
this analysis indicated that the degree of inflammation experienced between these groups is 
comparable. This finding agrees with the clinical decision to address inflammation and perform 
revision surgery, and these markers (IL-10, IL-12p70, IL-13, IL-17A, IL-4, and TNF-α) may show 
promise as helpful diagnostic monitoring markers for patients suffering from inflammatory 
complications in the absence of infection.  
 
While this study had several limitations (i.e., single operating surgeon, heterogeneous 
cohort of patients, pathogen variability), it represents a novel characterization of tissue-level 
cytokines across different anatomical locations in response to implants as well as infection-specific 
inflammation. These cytokines may give insight into the health of localized tissue following these 
procedures, and the results highlight the utility of investigating a localized view of tissue health by 
testing tissues surrounding the joint following these procedures. At the time of publication, all 
patients had reached at least the one-year post-operative follow up without need for revision with 
no recurrent infections, and the predictive value of these cytokines for successful surgical 
outcomes is of interest in future studies. These cytokines could potentially be incorporated to intra-
operatively assess the degree of inflammation during surgery, providing information in real time 
about the viability of tissues for debridement. A more focused investigation of infection-specific 
markers IL-1α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, and MIP-1β could provide insight into the 




In conclusion, this exploratory pilot study identified several cytokines that exhibited higher 
concentrations in response to implant-related and infection-specific post-operative inflammation. 
Some of these cytokines have been previously implicated in chronic inflammation and infection 
following TKA and TKR on a systemic level [11, 12, 30-33], and this study confirmed this trend 
on a localized tissue level and identified implant-related and infection-specific tissue-level 
cytokines. Previous studies have already illustrated that local inflammation is much more 
important for early post-operative recovery for a few markers [6], and this study expanded on that 
knowledge to provide an extended view of inflammatory cytokines involved in tissue health. 
Additionally, spatially dependent responses in cytokine concentrations were observed for IL-1α 
and IL-1β when both implant and infection were present, indicating that proximity to infection is 
important in the response to PJI. Future work will focus on understanding the upstream and 
downstream factors associated with cytokine response in these chronic inflammatory scenarios. 
 
Overall, investigating the localized tissue-level cytokines to understand implant-related 
and infection-specific inflammatory complications following knee arthroplasty offered insight into 
localized response and the disparities between septic and aseptic inflammation in these surgical 
scenarios. Although this study did not control for age, sex, or BMI, these cytokines were not 
significantly correlated to these variables, suggesting these were not confounding factors (Table 2) 
in this study. Future work will include a larger cohort of patients to control for these factors and 
other comorbidities. Ultimately, this study provided a basis to study these cytokines in surgical 
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3. Tissue-Level Cytokines in a Rodent Model of Implant-Associated Inflammation and 
Infection2 
Systemic cytokine concentrations have been extensively studied in implant-associated 
infections, providing sensitive diagnostic markers. However, less is known about the relationships 
of tissue-level cytokines surrounding the joint. The aim of this study was to define the cytokine 
profiles of tissues to investigate the use of these cytokines as markers of debridement in chronic 
joint infection. Using a rodent model, muscle samples were obtained from rats following Kirschner 
wire implantation and infection with Staphylococcus aureus to determine if: 1) differences exist 
in cytokine concentrations with proximity to infection, and 2) localized infection-specific markers 
can be identified on a tissue level to potentially serve as debridement markers in the future. 
Samples were collected from 4 distinct locations, and the concentrations of IL-1α, IL-1β, IL-4, IL-
5, IL-6, IL-10, IL-12p70, IL-13, GM-CSF, IFN-, and TNF-α were quantified in each sample, 
relative to the amount of tissue. Cytokine concentrations differed with proximity to the joint when 
implant or infection was present, and tissues at the operative knee joint showed the highest levels 
of most cytokines. Additionally, IL-1β, IL-4, and IL-6 showed promise, beyond diagnostics, as 
tissue-level indicators of infection response. Ultimately, this study illustrated that tissue-level 
evaluation provided insight into infection-specific response, and these markers may be useful for 
guiding debridement of implant-associated infections. 
 
 
2 Parts of this chapter have been published previously from Prince N, Penatzer JA, Shackleford TL, Stewart, EK, 
Dietz, MJ, and Boyd, JW. Tissue-Level Cytokines in a Rodent Model of Implant-Associated Infection. Journal of 




Implant-associated infections are a post-operative complication following total knee 
arthroplasty (TKA) procedures, affecting tens of thousands of patients per year in the United States 
[1]. Prosthesis-related infections, such as periprosthetic joint infection (PJI), affect the implant and 
surrounding tissues, and they can become chronic if bacteria form a biofilm on the prosthesis, 
creating a barrier against host response and antibiotic treatment [2]. This pressure on the host’s 
immune system combined with antibiotic resistance of the bacteria makes these infections difficult 
to reconcile and often results in high failure rates for treatment. Failure rates for all TKA 
procedures remain around 5% but are much higher with infected joints, with reported failure rates 
ranging from 14-25% [3-5].  
 
Early diagnosis of infection is critical, and a range of sensitive and specific biomarkers, 
including C-reactive protein (CRP), alpha-defensin, D-dimer, as well as cytokines like interleukin 
(IL)-1β, and IL-6, have been highlighted for their diagnostic utility in implant-associated infections 
like PJI [6-9]. Cultures, biopsies, and imaging techniques like PET-MRI and PET-CT have also 
been utilized with high sensitivity [10]. Prompt diagnosis can lead to better outcomes in surgical 
treatment, and serum biomarkers are most often used to aid diagnostic accuracy [11]. CRP is the 
most common diagnostic marker for implant infections, as it is both inexpensive and rapid [12], 
however, it suffers from low specificity. CRP levels can be high in a wide range of inflammatory 
processes, including the healing process following TKA procedures [13], so a high CRP level 
alone cannot positively confirm presence of infection. More recently, diagnostic efforts have 
shifted towards the identification and validation of cytokine markers.  
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The cytokine response to infection involves both pro- and anti-inflammatory cytokines that 
are recruited to the site [14-16]. Due to cytokines’ central roles in infection response, recent studies 
have investigated cytokine measurements for their diagnostic utility, especially in infections due 
to Staphylococcus aureus, the most common pathogen implicated in implant-associated infections. 
Pro-inflammatory cytokines IL-6, IL-1β, and tumor necrosis factor alpha (TNF-α) were first 
analyzed in synovial fluid of total hip arthroplasty (THA) patients and showed the ability to 
discriminate between aseptic and septic joints [17]. Since then, a variety of other cytokines, 
including interferon gamma (IFN-) [18], IL-4 [19], and IL-10 have also been pursued [20]. 
Frangiamore et al. identified IL-6 and IL-1β not only as markers with excellent diagnostic strength, 
but also noted their efficacy for monitoring response to infection treatment in synovial fluid [18]. 
While these cytokines have shown increased sensitivity and specificity for diagnosis in serum and 
synovial fluid, they have not been evaluated to expand their use beyond diagnostics into indicators 
of inflammatory immune response to aid treatment. 
 
Surgical debridement is utilized to treat chronic implant infections, but it relies heavily on 
subjective assessment of the state of the tissues surrounding the joint [21]. Understanding local 
tissue health is important for debridement of infected joints, as surgeons must delineate healthy 
from non-healthy tissue to promote infection resolution [22]. Complete removal of infected tissue 
is critical, as re-infection only requires a small number of bacteria [23].  Discerning healthy tissue 
from infected tissue can be challenging for clinicians, and insufficient debridement is a possible 
source for failure of treatment [24]. However, tissues are not intra-operatively analyzed beyond 
identification of the “4 C’s”- Color, Consistency, Contractility, and Capacity to bleed- and 
quantification of white blood cells.  Rarely, the presence or absence of bacteria via culture or 
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polymerase chain reaction (PCR) is utilized [17, 25]. Intra-operative assessment of tissues 
surrounding the joint for inflammatory cytokine markers could reveal important insights into tissue 
health, as these biomarkers are intimately related to infection response [6-8, 26] and wound 
resolution [27]. Further, identification of markers to guide debridement would benefit clinical 
decision making and allow surgeons to quantitatively assess the state of tissue in infected joints. 
Cytokine biomarkers that have previously been utilized for their roles in diagnostics may provide 
an avenue to pursue quantitative markers of debridement margins. Defining the tissue-level 
concentrations is the first step to evaluating the ability of cytokines as markers of healthy and non-
healthy tissue in chronic implant-associated joint infection. 
 
The purpose of this study was to assess tissue-level cytokine responses in a rodent model 
of chronic implant-associated infection, specifically with the purpose of highlighting new 
biomarkers of debridement for PJI. Cytokine concentrations were measured in skeletal muscle 
samples taken from Sprague-Dawley rats implanted with a Kirschner wire (K-wire) and exposed 
to S. aureus in the joint cavity. Levels of pro-inflammatory and anti-inflammatory cytokines were 
measured for the following targets: IL-1α, IL-1β, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13, IFN-γ, 
TNF-α, and granulocyte-macrophage colony-stimulating factor (GM-CSF). These factors were 
specifically chosen because of their use as diagnostic markers [28], roles in tissue healing [27], 
and the ability to give insight into overall tissue health [29]. Ultimately, this study aimed to expand 





 Materials and methods 
3.2.1 Animals 
All procedures were performed under the guidelines approved by the West Virginia 
University Animal Care and Use Committee (Approval #1803013294). Adult male and female 
Sprague-Dawley rats (Charles River, Wilmington, MA) were housed individually with a 12:12 
light/dark cycle and ad libitum access to standard chow and water. Animals were divided into 3 
groups: Sham (N=6), Implant Only (N=6), and Infection+Implant (Inf+Implant; N=6). Animal 
numbers for each group were obtained by performing a statistical power analysis using an alpha 
value of 0.05 and a difference to detect of 2. The power analysis was based on previous work to 
detect trauma-related cytokines, specifically IL-1β [30]. The power analysis necessitated a group 
size of N=6 when including both male and female rodents. All procedures were based on previous 
models of implant-associated infections in rats with K-wire implant [31-35], and tissues and blood 
were collected from all animals 21 days post-surgery.  
 
3.2.2 Experimental rat model of chronic localized infection 
Chronic joint infection was established based on literature protocols and previous work. 
Briefly, after adequate isoflurane anesthesia, the right leg was shaved and prepared for surgery. 
Under sterile conditions, the knee joint was exposed, and a hole was drilled into the medullary 
cavity of the femur. For Implant Only and Inf+Implant groups, a 3-cm (male) or 2-cm (female) by 
1-mm stainless steel K-wire was implanted into the bone. For Inf+Implant groups, 20 µL of 
1.8x107 CFU/mL suspension of Methicillin-sensitive Staphylococcus aureus (MSSA; ATCC 
25923, clinical isolate [Manassas, VA]) was injected into the medullary cavity after insertion of 
K-wire. This dose was chosen based on previous models to create a chronic localized infection but 
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to avoid systemic sepsis [36]. Additionally, a previous study found that inflammation due to 
surgery can persist until the 21-day time point, so this time point was chosen for tissue collection 
to optimize the measurement of infection-specific inflammatory cytokine responses [36]. Body 
temperature was monitored throughout the 21-day time period for presence of fever to ensure no 
systemic sepsis occurred. For all groups, the exposed joint was closed with 3-0 vicryl (Ethicon, 
Inc., Somerville, NJ) and staples, then Vetbond tissue adhesive (3M, St. Paul, MN) was applied 
externally. Buprenorphine SR (ZooPharm, Fort Collins, CO) was administered subcutaneously as 
an analgesic providing 72-hour pain relief [37]. Following closure of the knee joint, X-rays were 
taken at the 21-day time point and graded according to Aktekin et al [38]. Detailed methods and 
results for X-rays can be found in Appendix B. 
 
3.2.3 Tissue collection 
At 21-days post-surgery, the animals were again placed under anesthesia, as described 
above, and tissue and blood samples were collected. The 21-day post-surgery time point was 
chosen for sample collection as it allowed for the local effects in bone and soft tissue [31, 33, 36]. 
Once samples were collected, the animals were euthanized under isoflurane anesthesia with 
cardiac puncture, and one cc of Euthasol (Patterson Veterinary, Greenly, CO) was administered. 
Blood was collected in BD Vacutainer SST collection tubes (Becton Dickinson Vacutainer, 
Franklin Lakes, NJ), and serum was separated per manufacturer’s instructions. Blood samples 
were tested for white blood cell count (WBC) and red blood cell count (RBC) via standard medical 
lab testing; CRP (Invitrogen, Carlsbad, CA) and IL-6 levels (Invitrogen) were tested via enzyme-
linked immunosorbent assay (ELISA) in serum. These systemic measurement parameters can be 
found in Table 3.1. For tissue collection, four tissue locations were gently dissected from fascial 
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attachments, and skeletal muscle was collected. These locations were chosen to compare tissue-
level cytokines directly at the infected joint to nearby locations to evaluate infection-specific tissue 
responses across spatial gradients. Muscle samples were harvested from the following four 
locations: at the operative knee joint; 1.5±0.2 cm proximal from operative knee joint; 1.0±0.2 cm 
distal from operative knee joint; and from the contralateral leg knee joint. Figure 3.1 illustrates the 
sampling locations, labeled as A-D. Tissue samples were cultured to confirm presence or absence 
of S. aureus infection at 21 days post-surgery using established methods [39]. Bacterial load at the 
operative knee location for the three groups can be found in Table 3.1.  
 
 
Figure 3. 1. Sampling locations for muscle samples collected at 21 days post-surgery. Immediately 
prior to euthanasia, tissue samples were collected by gently dissecting skeletal muscle from fascial 
attachments. Four tissue locations were taken, denoted A-D. A) Contralateral leg knee joint; B) 
Operative leg, 1.5 cm proximal from knee joint; C) Operative leg knee joint; D) Operative leg, 




3.2.4 Sample preparation 
Samples were washed immediately with 1X cold phosphate-buffered saline (PBS) to 
remove blood and debris. Tissues were grossly dissected using a scalpel to remove scar and 
connective tissue, then stored at -80ºC. Samples were ground cryogenically and lyophilized for 24 
hours. For analysis, lyophilized tissue was thawed for 10 min at 4°C in 1 mL of cell lysis buffer 
(Bio-Rad, Hercules, CA) containing 20 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich, St. 
Louis, MO). Protein extraction was performed using methods adapted from Hulse et al [40]. 
Thawed samples were vortexed for 1-3 seconds and centrifuged at 5,000 x g for 5 minutes at 4°C. 
The supernatant was collected and tested for total protein content using a Pierce BCA Protein 
Assay Kit (Thermo Scientific, Waltham, MA), according to manufacturer’s instructions. 
Absorbance values for total protein content were determined on an Infinite M1000 multimode 
plate reader (Tecan, Raleigh, NC). 
 
3.2.5 Cytokine and phosphoprotein measurement 
To standardize samples for total protein content, tissue homogenates were individually 
diluted to a total protein concentration of 900 µg/mL with cell lysis buffer (Bio-Rad). Cytokine 
quantification was performed using a magnetic bead-based multiplex Rat Cytokine Th1/Th2 Kit 
(Bio-Rad) and measured using a Bio-Plex 200 suspension array system and Pro II Wash Station 
(Bio-Rad), according to the manufacturer’s instructions. The Th1/Th2 kit included the following 
cytokines: IL-1α, IL-1β, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13, GM-CSF, IFN-, and TNF-α. 
Results for these 11 cytokines were included in this analysis. Additionally, a total of 20 
phosphoproteins related to wound healing were tested via custom Bio-Rad multiplex 
phosphoprotein ELISA panels. The following targets were assessed, and sites of phosphorylation 
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are indicated in parenthesis. CREB (S133), HSP27 (S78), IκB-α (S32/S36), MEK1 (S217/S221), 
RPS6 (S235/S236), Smad2 (S165/S167), Src (Y416), Syk (Y352), c-Jun (S63), AKT (S473), p53 
(S15), p38 (Y180/Y182), p70S6K (T389), PTEN (S380), ZAP-70 (Y319), BAD (S136), ERK1/2 
(T202/Y204 T185/Y187), p90RSK (S380), VEGFR2 (Y1175), and NF-κB p65 (S536). 
Phosphoprotein results are discussed following the discussion of cytokines in section 3.4. 
 
3.2.6 Statistical analysis 
Data were analyzed using Prism 5 (GraphPad, San Diego, CA) and SAS JMP (Cary, NC). 
Standard curves for cytokine concentrations were generated for each protein using either a four- 
(4PL) or five-parameter logistic (5PL) regression model, depending on individual protein. 
Cytokine concentrations were determined using standard curve interpolation, then corrected by 
dilution factor. To compare cytokines, these values were standardized by tissue weight and 
converted to nanograms of cytokine per gram of tissue (ng/g). Implant and Inf+Implant groups 
were analyzed with respect to relative fluorescence compared to Sham group. Samples with 
fluorescence intensity values below the lower limit of quantitation (LLOQ) or above the upper 
limit of quantitation (ULOQ) were omitted from statistical comparisons. Outliers were identified 
using the 1.5 X interquartile range (IQR) rule and omitted from analysis. Two-way analysis of 
variance (ANOVA) with Bonferroni’s post-test was used to determine significant differences 
between Sham (N=6), Implant Only (N=6), and Inf+Implant (N=6) groups as well as between 
locations (i.e., in the Sham group, operative knee joint vs. operative leg proximal). Each tissue 
homogenate was tested in duplicate for cytokine concentration. Data are expressed as the mean ± 
standard error of the mean (SEM).  
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Table 3. 1. Clinically-Relevant Parameters at 21 Days Post-Surgery. At 21 days post-surgery, 
blood was collected and tested for RBC and WBC; IL-6 and CRP were measured in rat serum. 
Additionally, skeletal muscle samples were cultured to calculate bacterial load at the joint. RBC 
are shown in scientific notation as million(s) per microliter of blood; similarly, WBC are shown 
as thousand(s) per microliter of blood. CRP is shown in milligrams of CRP per liter of serum, and 
IL-6 is shown as picograms of protein per milliliter of serum. Bacterial load is shown as colony-
forming units (CFUs) per gram of tissue. Significance at p<0.05 is denoted with superscripts “S” 
for different than Sham, “C” for different than Implant Only, and “I” for different than Inf+Implant. 
Comparisons between groups were identified by one-way ANOVA with Tukey’s post-test. N.D. 
is an abbreviation for “not detected.” 
 
 
*Note: Bacterial load was calculated in tissue cultures, while all other parameters in Table 3.1 




 Cytokine Analysis of Rodent Tissues Between Sham, Implant Only, and Inf+Implant 
Groups 
Changes in tissue-level cytokine concentrations were observed between Sham, Implant 
Only, and Inf+Implant groups in implant-related and infection-specific manners. Overall, cytokine 
concentrations were higher for Implant Only and Inf+Implant groups compared to Sham. Intra-
group differences between locations were also investigated. Tissues at the operative knee (i.e., the 
site of debridement) were compared to all other locations. Cytokine profiles were compared 
 SHAM IMPLANT ONLY INF+IMPLANT 
RBC (x106/µL) 8.14±0.53 7.98±0.54 7.69±0.60 
WBC (x103/µL) 3.97±0.78 2.90±2.14 3.63±1.40 
CRP (mg/L) 428.51±164.92 620.24±296.11 789.39±181.20 
IL-6 (pg/mL) 24.50±0.69C,I 68.18±15.94S 118.06±13.50S 
Bacterial load 
(CFU/g)* 
N.D. N.D. 1.12x106±6.58x105 
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between these locations to look for spatially-dependent differences relevant for debridement. The 
operative knee and operative leg distal locations generally produced higher cytokine 
concentrations than the contralateral knee and operative leg proximal locations. The specific 
results are discussed over the following sections and can be seen in Figures 3.2-3.4. 
 
3.3.1 Eight cytokines elevated in implant-related manner 
Of the eleven cytokines, eight produced increases in both Implant Only and Inf+Implant 
groups compared to Sham (Figure 3.2): IL-1α, IL-5, IL-10, IL-12p70, IL-13, GM-CSF, IFN-, and 
TNF-α. These cytokines showed elevated concentrations at the operative knee and operative distal 
locations compared to Sham (p<0.05), but there were generally no significant differences between 
Implant Only and Inf+Implant groups (exceptions: IL-5 and IL-10 at the operative distal location). 
The profiles for Implant Only and Inf+Implant groups across different locations were similar for 
all eight of these cytokines. Group-dependent differences at p<0.05 are marked with letters S 
(significantly different than Sham group), C (significantly different than Implant Only group), and 
I (significantly different than Inf+Implant group). Additionally, all tissue locations were compared 
to the operative knee site to understand spatial differences, and significant differences at p<0.05 



































































































































































































































Figure 3. 2. IL-1α, IL-5, IL-10, IL-12p70, IL-13, GM-CSF, IFN-, and TNF-α concentrations in 
response to implant and infection. Concentrations are expressed as nanogram of cytokine per gram 
of tissue (ng/g). Statistically significant differences (p<0.05) in protein concentration between 
Sham (N=6), Implant Only (N=6), and Inf+Implant (N=6) groups are marked for each location: 
“S” represents different than Sham group; “C” denotes different than Implant Only group; “I” 
denotes different than Inf+Implant group. All locations were compared to the operative knee site 
within each group, and statistically significant differences between locations are marked with 




3.3.2 Three cytokines showed infection-specific response 
For three of the eleven cytokines, there was an increase in the Implant Only group, and a 
further increase in concentration was observed for the Inf+Implant group. IL-1β, IL-4, and IL-6 
showed an infection-specific trend, with the highest concentrations at the operative knee location 
(Fig. 3.3). The contralateral knee and operative leg proximal locations were not significantly 
different between Sham, Implant Only, and Inf+Implant groups (p>0.05). Group-dependent 
differences at p<0.05 are marked with letters S (significantly different than Sham group), C 
(significantly different than Implant Only group), and I (significantly different than Inf+Implant 
group) in Figure 3.3. Additionally, all tissue locations were compared to the operative knee site, 
and significant differences at p<0.05 between locations are marked with striped bars. The average 











































































































Figure 3. 3. IL-1β, IL-4, and IL-6 tissue concentrations in response to implant and infection. 
Concentrations are expressed as nanogram of cytokine per gram of tissue (ng/g). Statistically 
significant differences (p<0.05) in protein concentration between Sham (N=6), Implant Only 
(N=6), and Inf+Implant (N=6) groups are marked for each location: “S” represents different than 
Sham group; “C” denotes different than Implant Only group; “I” denotes different than 
Inf+Implant group. All locations were compared to the operative knee site within each group, and 
statistically significant differences between locations are marked with striped bars to indicate the 
concentration at that location is different than the operative knee at p<0.05. All labeling is 





3.3.3 Quadratic discriminant analysis and heat maps of cytokine profiles  
Total cytokine profiles were analyzed via QDA with SAS JMP on all measured cytokine 
responses at the operative knee location to compare Implant Only and Inf+Implant groups. The 
ANOVA data indicated that cytokine profiles were elevated in both of these groups, and QDA 
focused on the disparate profiles between Implant Only and Inf+Implant to identify cytokines most 
specific for infection on a tissue level. This analysis classified the combined concentrations of all 
cytokines observed into pre-determined groups (Implant Only, Inf+Implant) by plotting canonical 
scores calculated by the quadratic model. The 95% confidence intervals (CIs) are shown for each 
group, with Implant Only in red and Inf+Implant in blue. Biplot rays are shown to denote the 
degree of association of each cytokine with each group. There were no misclassifications in the 
model. Heat maps were constructed to show relative cytokine concentrations and compare the 
influence of cytokines on the cumulative cytokine profile for each group. Cytokine concentrations 
in ng/g were normalized between 0 (lowest value) and 1 (highest value) for each cytokine. Green 
represents a low relative cytokine concentration, and red represents a high relative cytokine 
concentration; the intensity of color denotes the degree of polarization. Relative levels in the Sham 
group were in the lowest 10th percentile for all cytokines, which can be observed by the intense 
green color. Colors in the Implant Only and Inf+Implant ranged from the 43rd percentile (mild 
green-yellow) to 100th percentile (bright red). The heat map results complement the findings of the 
QDA by illustrating the contrast in relative concentrations between Implant Only and Inf+Implant 











Figure 3. 4. QDA analysis (a) and heat map of relative cytokine concentrations (b). QDA analysis 
(a) shows the influence of the eleven cytokines on classification into Implant Only (red) or 
Inf+Implant (blue) groups. Biplot rays illustrate the degree of association with each group, and 
ellipses are drawn to show the mean ± 95% CI for the cumulative cytokine profiles. Heat maps of 
relative cytokine concentrations (b) illustrate the relative increases in concentration between the 
three groups for direct comparison between cytokines. For heat maps, cytokine concentrations 
(ng/g) were normalized between 0 and 1 for each cytokine to show relative increases. Green 








 Discussion of cytokine concentrations in response to implant and infection 
Implant-associated infections like PJI are devastating post-surgical complications and are 
the leading cause of implant failure in TKA procedures [1]. Diagnosis and treatment impose a 
significant burden for the health care system as well as individual patients, and the annual cost of 
infected revisions is projected to exceed $1.5 billion by the end of 2020 [41]. Cytokine 
measurements in synovial fluid and serum of patients suffering from chronic PJI have illustrated 
high sensitivity and specificity of these targets for diagnostic purposes [20]. However, the primary 
method for treatment of chronic, recurrent implant-associated infections is debridement, which has 
highly subjective endpoints [21]. Treatment has not progressed to more objective metrics, 
presenting a challenge for clinicians who are tasked with precise, complete removal of infected 
tissues. Cytokine biomarkers currently used for diagnostics may provide potential for use as 
quantitative markers for establishing intra-operative debridement margins between healthy and 
non-healthy tissue. In this study, eleven cytokines were analyzed in a rodent model of chronic 
implant-associated infection to identify biomarkers that have the potential to delineate infected vs. 
non-infected tissues. Ultimately, these cytokines could aid clinicians in establishing debridement 
margins using reliable, quantitative metrics.  
 
Eight cytokines exhibited implant-related increases in concentration at the operative knee: 
IL-1α, IL-5, IL-10, IL-12p70, IL-13, GM-CSF, IFN-, and TNF-α (Fig. 3.2). For these cytokines, 
Implant Only and Inf+Implant groups showed higher concentrations than the Sham group (p<0.05), 
but there were no significant differences between Implant Only and Inf+Implant groups directly 
at the operative knee. These cytokines have previously been linked to inflammation associated 
with prosthetics [42], and our results indicated that inflammation at the joint can be attributed to 
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the presence of a K-wire implant (Fig. 3.2). All of these cytokines gave the highest response 
directly at the operative knee location, with the exception of IL-1α for the Inf+Implant group, 
which had an unclear trend. Decreased cytokine profiles would suggest a return to healthy tissue 
[29], which is relevant to debridement, so all tissue locations were compared to the operative knee 
to investigate the spatially-disparate responses. IL-1α, IFN-, and TNF-α did not show the ability 
to reliably discriminate tissues across locations, and previous studies have noted low specificity in 
serum for these cytokines in implant-associated infections [43]. The ANOVA data in this study 
suggested they would not be reliable debridement markers (Fig. 3.2). Disparities between operative 
knee and operative distal sites for the Inf+Implant group were observed for IL-5, IL-10, IL-13, and 
IL-12p70, but these differences were not present in the Implant Only group. The Implant Only 
group still maintained elevated IL-5, IL-10, and IL-13 concentrations at the operative distal site 
(Fig. 3.2; p<0.05), but the Inf+Implant group showed a decrease at this location. These are three 
anti-inflammatory cytokines [44], and they all showed elevation at tissues downstream of the joint 
in the Implant Only group. IL-12p70 also appeared to follow this trend, but not at a statistically 
significant level (Fig. 3.2; p>0.05). IL-12p70 is an immunoregulatory cytokine with both pro- and 
anti-inflammatory functions and plays a role in cell proliferation during wound healing [45]. The 
exact mechanisms of cytokine dysregulation due to implant and infection are unknown, but the 
spatially disparate downstream effects observed for these cytokines could be due to a variety of 
factors, including vascular supply [46], atrophy [35], or differences in wound healing stages [47]. 
While outside the scope of this manuscript, the spatially disparate profiles of these cytokines due 
to foreign body implant warrant future investigation. GM-CSF was the only implant-related 
cytokine to show the expected spatially-dependent trend for both the Implant Only and Inf+Implant 
groups (Fig. 3.2; p<0.05). GM-CSF has been noted for its role in inflammatory autoimmune 
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diseases and has shown increased concentrations in response to pro-inflammatory stimuli [48]. 
However, the QDA illustrated it was not a good differentiator of inflammation due to implants vs. 
inflammation due to infection (Fig. 3.4). Overall, the data in this study indicated that none of the 
implant-related cytokines were good indicators of debridement margins at the operative knee.  
 
Infection-specific trends in cytokine responses were present for IL-1β, IL-4, and IL-6 in 
this study (p<0.05). These cytokines have been noted for their roles in infection, demonstrating 
increases in serum concentrations in response to joint infection [49-51]. In this study, these 
cytokines showed the highest increase in response directly at the operative knee (Fig. 3.3), 
highlighting the importance of tissue-level disparities in response to infection. IL-1β and IL-6, two 
pro-inflammatory cytokines, have demonstrated diagnostic utility and were elevated in response 
to infection in this study [52]. Infection with S. aureus is known to trigger IL-1β release and is 
concomitant with cell death [53]. IL-6 is synthesized in infectious lesions to send out a warning 
signal of tissue damage, which is then recognized by pathogen-recognition receptors (PRRs), and 
it is an early initiator of infection-related inflammation [54]. Both IL-1β and IL-6 produce signals 
during infection that ultimately trigger cell death pathways [55]. For IL-1β, all locations were 
significantly different than the operative knee (p<0.05) for both Implant Only and Inf+Implant 
groups (Fig. 3.3). IL-6 only reflected this trend in the Inf+Implant group, but the increased 
concentrations at the operative knee location compared to Implant Only suggested it is still a good 
indicator of infection presence (p<0.05, Fig. 3.3). IL-4, an anti-inflammatory cytokine, activates 
the Stat6 pathway in infection and suppresses cell-mediated death [56]. IL-4 trends were similar 
to IL-6, and only the Inf+Implant group showed a significant decrease in concentration at the 
operative distal location (p<0.05). QDA and heat maps were constructed to comparatively assess 
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the contributions of these cytokines to each of the groups. The heat maps showed relative 
concentrations of cytokines and suggested IL-1β, IL-4, and IL-6 may all serve as good indicators 
of infected tissues at the joint. Further analysis of QDA data indicated IL-1β and IL-6 are strongly 
indicative of Inf+Implant tissues (Fig. 3.4), while IL-4 plays a role in both Implant Only and 
Inf+Implant groups when considering total cytokine contributions. The QDA demonstrated that 
IL-1β and IL-6 show a stronger relationship to Inf+Implant tissues and may serve as better 
indicators for debridement.  
 
The results of this study demonstrated that tissue-level concentrations of IL-1β and IL-6 
are strongly indicative of infected tissues through ANOVA comparisons as well as QDA 
classifications. These cytokines have previously been validated for diagnostics of implant-
associated infections in serum, and they have established roles in infection response. The findings 
presented here offer an opportunity to expand their utility beyond diagnostics as tissue-level 
indicators of infection. These results provided evidence that these cytokines are worth pursuing in 
the development of objective biomarkers to guide debridement and treatment of chronic implant-
associated infections. Ultimately, this study laid the foundation to develop quantitative, tissue-
level biomarkers to aid surgical decision making. In the future, these cytokines could be 




 Phosphoprotein and Ingenuity Pathway Analysis (IPA) to understand spatially-
disparate responses 
 The cytokine analysis in this study provided important insights into the tissue-level immune 
response to chronic infection and highlighted biomarkers that could be used for debridement of 
chronically infected tissues, but the analysis also provoked questions regarding the responses of 
tissues upstream and downstream of the operative site. The initial cytokine study primarily 
addressed the response directly at the operative knee, as this is the most relevant for surgical 
debridement, but the responses of proximal and distal tissues also showed altered concentrations 
of some cytokines. Increases in all cytokines, either due to implant or infection, suggested some 
disruption of normal inflammatory immune response (Figs. 3.2 and 3.3), and evidence suggests 
that excessive inflammation caused by these cytokines can delay wound healing [62]. Elevated 
cytokine levels at proximal or distal locations could suggest that healing processes in these tissues 
are compromised, so wound healing phosphoproteins were also assayed to investigate the 
responses proximal and distal to the operative knee. 
 
 GM-CSF, IL-4, and IL-1β all showed the expected trend with elevation at the operative knee, 
and other locations in the Implant Only and Inf+Implant groups were statistically significantly 
different from the operative knee at p<0.05 (with one exception: IL-4 in the Implant Only group 
operative knee vs. operative distal, but it appeared to follow the trend; Figs. 3.2 and 3.3). However, 
the other cytokines showed elevated cytokine concentrations either at the op prox or op dist 
locations. Four cytokines, IL-5, IL-10, IL-12p70, and IL-13 showed elevated levels in response to 
implant, and the operative distal location maintained higher concentrations of these cytokines (Fig. 
3.2). While IL-6, one of the infection-specific cytokines, showed significant differences between 
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locations in the Inf+Implant group (p<0.05), the Implant Only group did not show any significant 
differences between locations. Other cytokines, IL-1α, IFN-γ, TNF-α showed less spatial disparity 
and did not inform differential wound healing responses between locations. All of these cytokines 
have established roles in acute infection response [6-9, 14-16, 18-20], but chronic infections can 
disrupt cell signaling networks associated with these responses [63, 64]. The inflammation due to 
foreign body implant, infection, or both may be negatively impacting the ability of tissues to heal, 
but cytokines alone are not enough to understand these wound healing cascades. 
 
 To investigate the networks of tissue healing between disparate locations, phosphoprotein 
analysis was conducted as a follow-up to the cytokine work. Network analysis can give 
information about the connectivity of wound healing signaling and highlight key mediators of the 
response [65, 66]. QIAGEN’s Ingenuity Pathway Analysis (IPA) software application is a 
commonly used tool for creating and analyzing complex biological networks. This method uses 
both experimental and literature-derived data to connect different targets, referred to as “nodes,” 
resulting in a model of response. IPA utilizes the Ingenuity Knowledge Base, a repository derived 
and curated from previous studies, to identify highly interconnected “Focus Genes” and construct 
a network [67]. Top molecular and cellular function associated with the networks are also reported 
by IPA, which allows researchers to further probe into which cellular processes may be activated 




 Methods for phosphoprotein and network analysis 
3.6.1 Statistical analysis of phosphoproteins 
Phosphoprotein data was acquired using multiplexed magnetic bead-based assays (Bio-
Rad) and measured using a  Bio-Plex 200 suspension array system (Bio-Rad), as described in 
section 3.2.5. Data were analyzed using Prism 5 (GraphPad, San Diego, CA), and relative 
phosphorylation levels were calculated from fluorescence intensity values. Differences between 
groups and tissue locations were compared based on relative phosphorylation in samples 
standardized to a total protein concentration of 900 µg/mL. Samples with fluorescence intensity 
values below the lower limit of quantitation (LLOQ) or above the upper limit of quantitation 
(ULOQ) were omitted from statistical comparisons. Outliers were identified using the 1.5 
X interquartile range (IQR) rule and removed. Two-way analysis of variance (ANOVA) with 
Bonferroni’s post-test was used to determine significant differences between Sham (N=6), Implant 
Only (N=6), and Inf+Implant (N=6) groups as well as between locations (i.e., in the Sham group, 
operative knee joint vs. operative leg proximal). Each tissue homogenate was tested in duplicate. 
Data are expressed as the mean ± standard error of the mean (SEM). ANOVAs are shown for 16 
out of the total 20 phosphoproteins tested. Five phosphoproteins, HSP27 (S78), Src (Y416), p53 
(S15), ZAP-70 (Y319), and NF-κB p65 (S536), did not produce statistically significant trends (data 
not shown). 
 
3.6.2 Construction of IPA networks 
 Both cytokines and phosphoproteins were included in the creation of IPA networks, and all 
31 targets were included (11 cytokines and 20 phosphoproteins), regardless of whether or not they 
produced statistically significant ANOVA comparisons between groups or locations at p<0.05. 
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IPA uses the relative up- and down-regulation of targets compared to a control to construct 
networks, so all 31 targets were normalized by correcting the concentration/relative 
phosphorylation values at each location to the contralateral leg for every individual animal. This 
method allowed for correction arising from biological variability and provided some correction for 
systemic inflammation. These normalized responses were investigated with QIAGEN’s 
Ingenuity® Pathway Analysis (IPA®, QIAGEN, Redwood City), and proposed networks were 
created for each group (Sham, Implant Only, Inf+Implant) at each of the three locations (Op Prox, 
Op Knee, Op Dist). The IPA networks consist of nodes from the experimental dataset and 
literature-derived projected nodes likely to be involved, identified by Ingenuity Knowledge Base. 
Up- and down-regulated responses are color coded using red and green, respectively. IPA also 
reported top up- and down-regulated targets for each of the nine networks, based on changes in 
expression across groups.   
 
 Results of phosphoprotein data and IPA networks 
3.7.1 Ten phosphoproteins were elevated in response to implant or infection 
 Phosphoprotein levels were compared between groups and locations, and ten of the twenty 
phosphoproteins tested exhibited increased phosphorylation levels when implant or infection was 
present: MEK1 (S217/S221), RPS6 (S235/S236), p70S6K (T389), PTEN (S380), BAD (S136), 
p90RSK (S380), VEGFR2 (Y1175), ERK1/2 (T202/Y204 T185/Y187), IκB-α (S32/S36), and c-
Jun (S63). Trends between the three groups are specifically discussed in the following paragraphs. 
 MEK1, RPS6, p70S6K, PTEN, BAD, p90RSK, VEGFR2, and IκB-α showed increases in 
both Implant Only and Inf+Implant groups compared to Sham at a statistically significant level 
(p<0.05) at a minimum of one tissue location. ERK1/2 also appeared to follow this trend, but it 
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did not produce statistically different phosphorylation levels compared to the Sham group (Fig. 
3.5). Additionally, some of these cytokines produced significant comparisons between the Implant 
Only and Inf+Implant groups at p<0.05 at certain tissue locations. p70S6K and BAD showed 
differences between Implant Only and Inf+Implant proximal to the operative site (p<0.05), and 
p90RSK was significantly higher in Inf+Implant compared to Sham and Implant Only directly at 
the operative site (Fig. 3.5, p<0.05). c-Jun did not show as much of a disparity in relative 
phosphorylation levels between the three groups compared to the other targets tested, with the only 
significant comparison at p<0.05 being Inf+Implant at the operative knee compared to both Sham 


























































































































































































































































































































Figure 3. 5. Ten phosphoproteins showed elevated levels in response to implant and infection. 
Relative phosphorylation levels were compared between all samples at a concentration of 
900 µg/mL total protein. Statistically significant differences (p<0.05) in relative phosphorylation 
between Sham (N=6), Implant Only (N=6), and Inf+Implant (N=6) groups are marked for each 
location: “S” represents different than Sham group; “C” denotes different than Implant Only group; 
“I” denotes different than Inf+Implant group. All locations were compared to the operative knee 
site within each group, and statistically significant differences between locations are marked with 





3.7.2 Five phosphoproteins showed increased responses proximal or distal to the 
operative knee 
 Of the twenty phosphoproteins tested, five showed trends of increased phosphorylation levels 
proximal or distal to the operative knee in either the Implant Only group, Inf+Implant group, or 
both. CREB (S133), Smad2 (S165/S167), and Syk (Y352) showed phosphorylation levels at the 
operative distal site that were significantly higher than the Implant Only or Sham groups (p<0.05). 
For all three of these targets, the operative distal location was not significantly different at p<0.05 
from the operative knee site within the Inf+Implant group. In other words, phosphorylation of 
CREB, Smad2, and Syk in the Inf+Implant group was similar between these two locations and 
significantly higher (p<0.05) than the other two groups. 
 
 Phosphorylation levels of AKT (S473) and p38 (Y180/Y182) trended upward in both the 
Implant Only and Inf+Implant groups and were higher than levels in the Sham group (Fig. 3.6). 
Phosphorylated p38 was significantly higher at the operative distal site than the operative knee in 
the Inf+Implant group (p<0.05); the Implant Only group only exhibited an increase, but it was not 
at a statistically significant level. Additionally, both AKT and p38 were present at significantly 
higher levels in the operative proximal tissues compared to operative knee in the Implant Only 




































































































































































Figure 3. 6. Five phosphoproteins showed elevated levels proximal or distal to the opeartive knee 
site. Relative phosphorylation levels were compared between all samples at a concentration of 
900 µg/mL total protein. Statistically significant differences (p<0.05) in relative phosphorylation 
between Sham (N=6), Implant Only (N=6), and Inf+Implant (N=6) groups are marked for each 
location: “S” represents different than Sham group; “C” denotes different than Implant Only group; 
“I” denotes different than Inf+Implant group. All locations were compared to the operative knee 
site within each group, and statistically significant differences between locations are marked with 





3.7.3 IPA revealed differences in wound healing responses 
 IPA was used to construct network of responses for all nine networks (3 groups, 3 tissue 
locations) from experimentally-derived and literature-derived data (Fig. 3.7). A qualitative 
analysis of connectivity of the networks was conducted by quantifying the number of edges in 
each individual network. An “edge” is a connection between two nodes, and IPA draws edges 
between nodes by quantifying the overlap via a Fisher’s Exact Test with significance set to p<0.01. 
A higher number of edges in a network signifies greater connectivity, since there are more 
relationships between sets of nodes. In this study, the following number of edges were identified 
in each network (with number of edges shown in parenthesis after the network name): Op Prox 
Sham (101), Op Knee Sham (99), Op Dist Sham (101), Op Prox Implant Only (98), Op Knee 
Implant Only (104), Op Dist Implant Only (99), Op Prox Inf+Implant (99), Op Knee Inf+Implant 
(99), Op Dist Inf+Implant (96). The average number of edges was 99.6, so all networks were 
within 5 edges of the average.  
 
 While the connectivity was similar between all nine networks, construction (i.e., the position 
of nodes) differed. An analysis of important up- and down-regulated targets was conducted to 
better understand which nodes may differ between the networks. Changes in expression were 
compared, with a positive change signifying up-regulation and a negative change denoting down-
regulation. The top three nodes for up- and down-regulation from the experimental data set were 
identified at the operative knee joint, and the behavior of these nodes is graphed between all three 










Figure 3. 7. Ingenuity Pathway Analysis (IPA)-generated networks. Proposed networks used 
relative cytokine and phosphoprotein responses. Nodes are illustrated in a “heat map” coloring 
scheme, with red denoting up-regulation, green denoting down-regulation, and the intensity of 
color correlates to the intensity of relative response. The networks are supplemented with other 
nodes likely to be involved, as identified in the Ingenuity Knowledge Base. A solid line represents 







































































































Figure 3. 8. Comparison of top up- and down-regulated nodes compared to the operative knee. 
Differences in expression for the top three up-regulated and down-regulated nodes from the 
experimental data set are shown for each of the three groups. The average expression change ± 







 Discussion of Wound Healing Network Analysis  
 Network analysis provided some clarity on the aspects of tissues upstream and downstream 
from the operative knee that may affect immune response at operative knee location. It is well 
established that the cytokines investigated in this study play important roles in the inflammatory 
response to implants or infection [2], and to better understand the impacts on cell signaling related 
to wound healing, phosphoproteins were included in a follow-up analysis. These phosphoproteins 
are related to wound healing processes such as proliferation [68-70], fibrosis and establishment of 
connective tissue [71-73], and inflammatory apoptosis [74-76]. Changes in expression levels of 
these targets between locations may highlight some of the disruptions observed for cytokines at 
the operative proximal or operative distal sites.  
 
 While the overall connectivity of networks of cytokines and phosphoproteins analyzed by 
IPA was similar based on the number of edges, the construction differed as well as the up- and 
down-expression of nodes. Top contributors were identified in each of the nine networks by 
highlighting the top three up-regulated and down-regulated nodes. Changes between tissue 
locations for these top network contributors may indicate targets that highly influence the response 
[77]. Within the Sham group, comparison of the top up- and down-regulated targets between 
locations revealed that phosphoproteins p70S6K and ERK1/2 were higher at proximal and distal 
locations compared to the operative knee (p<0.05), and both of these phosphoproteins are 
important for proliferative processes in wound healing [70]. Cytokine IL-5 expressed higher 
directly at the joint than the proximal location (p<0.05) but was not significantly different than the 
distal location (Fig. 3.8). IL-5 is a mediator of TH2 immunity and promotes eosinophil-mediated 
inflammation [78], so its elevation at the operative knee and operative distal locations may signify 
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that there is a higher degree of inflammation at these locations, which agrees with the cytokine 
data as a whole (Figs. 3.2 and 3.3). In the Implant Only group, pro-inflammatory IL-1β was 
significantly lower at the proximal and distal locations compared to the operative knee (p<0.05), 
and IL-12p70 showed the same trend at the proximal tissue (p<0.05), suggesting that a potent pro-
inflammatory response is present at the operative knee in response to implants. Three 
phosphoproteins, MEK1, p38, and p53 were all significantly higher at both the proximal and distal 
locations compared to the operative knee (p<0.05). These phosphoproteins are important for 
wound healing during multiple stages, including proliferation [69], migration [74], and apoptotic 
processes in wound healing [71]. Following the same trend at the Sham group, the Implant Only 
group showed higher cytokine expression at the operative knee and lower levels of wound healing 
phosphoproteins. In the Inf+Implant group, pro-inflammatory IL-1β was significantly higher at 
the operative knee than proximal and distal to this site (p<0.05), and TNF-α was lower in proximal 
tissues (p<0.05). Phosphoprotein p38 was expressed in higher levels at the operative distal location 
compared to the joint site (p<0.05). 
 
There were several limitations to this study. The cytokine concentrations were measured 
in rodents that were treated with anesthetics and analgesics. Many studies have observed 
suppression of cytokine production following administration of these agents [57, 58]. The use of 
isoflurane and buprenorphine was specifically chosen to avoid significant modulation of cytokine 
response [37]. Buprenorphine has been shown to have no significant effect on cytokine production 
in rodents [59]. While isoflurane has been shown to increase levels of pro-inflammatory cytokines 
like IL-1β, IL-6, and TNF-α [60], comparison with the Sham group still illustrated an increase in 
levels of these cytokines due to both implants and infection. Many approaches to studying chronic 
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joint infections like PJI have been pursued in literature [61], and this study represents only one 
infecting organism, S. aureus, at one post-surgical time point in a non-load bearing K-wire implant 
model. Future studies will focus on varying durations of infection, include other infecting 
organisms, and multiple inoculation doses. 
 
 In conclusion, the follow-up network analysis provided some insight into the spatially-
dependent tissue response, which may have implications healing. When comparing the operative 
proximal and operative distal locations to the operative knee, phosphoproteins identified in IPA as 
top contributors- p70S6K, ERK1/2, MEK1, p38, and p53- were consistently higher at proximal 
and distal sites (Fig. 3.8). Cytokines IL-5, IL-1b, IL-12p70, and TNF-α were also identified as top 
contributors in IPA, and these were consistently higher at the operative knee. Further, IL-5, IL-
12p70, and TNF-α were significantly lower proximal to the joint in the Sham, Implant Only, and 
Inf+Implant groups, respectively, suggesting that the distal location may maintain a higher degree 
of inflammation similar to the operative site. The network analysis allowed identification of likely 
contributors to differences in healing responses, and these results suggested that cytokines 
dominate the healing response at the operative knee in all three groups, while wound healing-
related phosphoproteins govern the response at proximal and distal sites.     
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4. Impact of Cytokines and Phosphoproteins in Response to Chronic Joint Infection3 
 The early cellular response to infection has been investigated extensively, generating 
valuable information regarding the mediators of acute infection response. Various cytokines have 
been highlighted for their critical roles, and the actions of these cytokines are related to intracellular 
phosphorylation changes to promote infection resolution. However, the development of chronic 
infections has not been thoroughly investigated. While it is known that wound healing processes 
are disrupted, the interactions of cytokines and phosphoproteins that contribute to this 
dysregulation are not well understood. To investigate these relationships, this study used a network 
centrality approach to assess the impact of individual cytokines and phosphoproteins during 
chronic inflammation and infection. Tissues were taken from patients undergoing total knee 
arthroplasty (TKA) and total knee revision (TKR) procedures across two tissue depths to 
understand which proteins are contributing most to the dysregulation observed at the joint. Notably, 
p-c-Jun, p-CREB, p-BAD, IL-10, IL-12p70, IL-13, and IFN-γ contributed highly to the network 
of proteins involved in aseptic inflammation caused by implants. Similarly, p-PTEN, IL-4, IL-10, 
IL-13, IFN-γ, and TNF-α appear to be central to signaling disruptions observed in septic joints. 
Ultimately, the network centrality approach provided insight into the altered tissue responses 






3 Parts of this chapter have been published previously from Prince N, Penatzer JA, Dietz, MJ, and Boyd, JW. Impact 




 Acute responses to inflammation and infection have been well studied in literature, and 
these studies have highlighted important roles for many cytokines [1–3] and phosphoproteins [4,5] 
in early inflammatory immune processes. The coordinated series of signaling events involves the 
recruitment of pro-inflammatory regulators like IL-1α, IL-1β, and IL-6 [6–8] to the site, provoking 
intracellular phosphorylation changes of many mitogen-activated protein kinase (MAPK/ERK) 
mediators [9–11]. This acute inflammatory response to infection is predictable. However, less is 
known about the transition that leads to the development of chronic infections [12]. Chronic, 
persistent infections are challenging to treat and can present a challenge for clinicians [13]. 
Periprosthetic joint infection (PJI) is an infection surrounding a prosthetic knee and represents one 
example of localized infections that can transition into a chronic state. Dysregulation of immune 
mediators has been observed systemically for PJI [14,15], but the mechanisms that lead to these 
signaling disruptions have not been investigated [16]. PJI affects approximately 40,000 patients 
per year in the United States [17], and resolving these chronic infections is a high priority for 
clinicians. These patients suffer from chronic inflammation surrounding the joint due to presence 
of implant as well as infection [18,19]. This compound inflammation makes the tissue-level 
response difficult to understand using traditional statistical approaches. Further investigation into 
the tissue-level disruptions that lead to chronic infection and inflammation may allow a better 
understanding of how best to address these conditions. 
 
Network analysis approaches allow for a global evaluation of these complex, tissue-level 
disruptions [20]. Traditional statistical methods for evaluating these contributions may be limited, 
as they can only evaluate one component individually. Conversely, network analysis approaches 
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allow for an understanding of the interactions of different components with respect to the entire 
signaling network [20]. Currently, pathway analysis software like Ingenuity Pathway Analysis 
(IPA), Cytoscape, and iPathway Guide are used to analyze these types of datasets from a network 
perspective, and these tools offer an enriched understanding of biological networks. These 
applications allow users to construct networks, analyze molecular functions, and identify disease 
states using experimental and literature-derived data [21,22]. 
 
Beyond literature-based enrichment of data, mathematical modeling, such as network 
centrality parameter analysis, can be used to dissect large datasets and understand relationships 
between the individual components. Network centrality parameters assign quantitative values to 
every measured target (node) to describe how central each target is relative to all other nodes in 
the network. Some examples of centrality parameters are degree (number of direct neighbors), 
diameter (maximum distance between nodes in the network), and radiality (shortest path between 
a node and all other nodes, normalized to network diameter) [23]. 
 
A node with a high radiality indicates that node is central to the network, and networks 
with mostly high radiality nodes are behaving in an organized manner. Conversely, nodes with 
low centrality values have peripheral roles, and networks with many low radiality nodes may be 
interpreted as an open cluster of proteins that are connecting to other regulatory molecules [23]. 
By focusing on the nodes with low centrality outcomes, it may be possible to understand which 
peripheral nodes are contributing to the dysregulation observed in networks of chronic 
inflammation and infection that occur in TKR patients, especially those suffering from PJI. 
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Radiality has been used in literature to probe biological networks and garner information about 
protein-protein interactions to understand chronic inflammatory conditions like diabetes [24], 
cancer [25], and chronic viral infections [26]. Ultimately, using radiality to evaluate these signaling 
networks allowed an opportunity to identify new therapeutic targets to combat these conditions. 
Evaluating the nodes that are most central and most peripheral in chronic infections like PJI may 
yield similar benefits. 
 
In this study, nine cytokines and twenty-one phosphoproteins were measured in tissues 
surrounding the knee joint to evaluate differences between native response in primary TKA, 
chronic inflammatory response in aseptic TKR, and chronic infection response in septic TKR. Two 
tissue depths were evaluated for each group: adjacent tissue layer (ATL), unhealthy tissue that is 
close to the joint and requires removal; and radial tissue layer (RTL), healthy tissue that does not 
need to be removed. The dataset was examined using IPA and network centrality radiality to allow 
both qualitative and quantitative evaluations of cytokine and phosphoprotein contributions. A 
comparison of radiality values between primary TKA, aseptic TKR, and septic TKR allowed for 
a narrowing of the nodes with particularly distinct responses. These nodes may have important 
contributions to the disruption of normal cell signaling events. In the future, a focused analysis of 
these protein targets may facilitate the development of new therapeutics to combat persistent 







 Materials and methods 
4.2.1 Patient cohort 
All subjects gave informed consent for inclusion in the study, and the study was conducted 
in accordance with the Declaration of Helsinki. Following Institutional Review Board (IRB) 
approval (IRB protocol #1709745853) and patient consent, six patients undergoing primary total 
knee arthroplasty (TKA) and eleven patients undergoing total knee revision (TKR) procedures 
participated in the study (8 males and 9 females; aged 45–82 years; body max index [BMI] 24.6–
43.7; information can be found in Table 4.1), and subjects were recruited over a 12-month period. 
All six primary TKA patients were undergoing elective surgery for total replacement of the knee 
joint with a diagnosis of osteoarthritis. In the TKR group, patients were further characterized into 
aseptic and septic revision procedures. Patients with aseptic revisions (N = 5) were undergoing 
revisions due to failures of the prosthetic joint but did not show presence of infection. Patients with 
septic revisions (N = 6) met clinical criteria for a PJI diagnosis, as defined by the Musculoskeletal 
Infection Society (MSIS) criteria [27]. All six patients diagnosed with PJI had positive tissue 
cultures on the day of surgery: four tested culture positive for Staphylococcus epidermidis, one for 
Methicillin-sensitive Staphylococcus aureus (MSSA), and one for Enterobacter cloacae. All 









Table 4. 1. Patient Information. Six primary TKA and eleven revision TKR patients were enrolled 
in the study, creating a heterogenous cohort of males and females varying in age (45-82 years) and 
comorbidities. Primary TKA patients have ID format P#; revision TKR patients have ID format 
F#. This table lists general patient information including the pathogen for which each septic patient 
tested culture-positive following testing on the day of surgery. Serum CRP values were obtained 
pre-operatively in the revision setting. Cultures were obtained from intraoperative tissue samples.   
 
ID Sex TKA/TKR BMI(kg/m2) Diabetic (Y/N) CRP (mg/L) Culture 
P1 F TKA 33.8 N N/A Negative 
P2 F TKA 39.8 N N/A Negative 
P3 F TKA 39.8 N N/A Negative 
P4 M TKA 29.7 Y N/A Negative 
P5 M TKA 24.6 N N/A Negative 
P6 M TKA 27.2 N N/A Negative 
F1 F TKR- Aseptic 28.2 N 4.3 Negative 
F2 F TKR- Aseptic 29.8 N 0.2 Negative 
F3 F TKR- Aseptic 33.9 N <1 Negative 
F4 M TKR- Aseptic 40.4 Y 3.6 Negative 
F5 M TKR- Aseptic 26.2 N 2.1 Negative 
F6 F TKR- Septic 43.7 N 28.8 S. epidermidis 
F7 F TKR- Septic 30.8 Y 161.4 S. epidermidis 
F8 F TKR- Septic 41.9 N 21.7 E. cloaecae 
F9 M TKR- Septic 36.2 N 33.5 MSSA 
F10 M TKR- Septic 33.8 Y 3.8 S. epidermidis 





4.2.2 Collection of tissue samples 
 All TKA and TKR procedures were performed by a single surgeon with standard 
debridement and washing protocols. Debridement during TKA and TKR is the removal of 
unhealthy tissue surrounding the joint [28]. Tissues were collected at a total of four distinct 
anatomical locations, shown in Figure 4.1. The solid line circle represents location 1: medial 
femoral condyle (F); the dashed line circle represents location 2: medial tibial plateau (T); the solid 
line square represents location 3: lateral gutter (LG); and the dashed line square represents location 
4: posterior capsule (PC). These tissues were collected at two tissue layers, the adjacent tissue 
layer (ATL) and radial tissue layer (RTL). The ATL samples came from the initial debridement; 
these tissues are removed during surgery to promote better wound healing. RTL samples were 
taken from a tissue layer further removed from the joint after the surgeon completed debridement. 
The difference in depth of the RTL tissues and ATL tissues was ~1 cm. Anatomical locations 1–4 
were collected for the ATL layer, and locations 1–3 were collected for the RTL layer. Location 4 
(PC) could not be taken in the RTL layer due to proximity to neurovascular structures. Therefore, 














Figure 4. 1. Map of approximate tissue collection locations, shown with prosthetic implant. 
Seven tissue samples were taken for each patient; (1) the solid circle represents the medial 
femoral condyle (denoted as F); (2) the dashed circle represents the medial tibial plateau 
(denoted as T); (3) the solid square represents the lateral gutter (denoted as LG); (4) the dashed 
square represents the posterior capsule (denoted as PC). Locations 1–4 were taken for the ATL 
layer, and locations 1–3 were taken for the RTL layer; separation between ATL (unhealthy 
tissue, closer to joint) and RTL (healthy tissue, further from joint) was approximately 1 cm, 
depending on individual patient. 
 
4.2.3 Sample preparation 
Tissues were collected during TKA and TKR procedures in the operating room and 
immediately stored on dry ice. Once all tissues had been collected for an individual patient, they 
were washed with 1X cold phosphate-buffered saline (PBS) to remove blood and debris. Tissues 
were grossly dissected using a scalpel to remove scar tissue, then stored at −80 °C. When samples 
had been collected for all patients, tissues were thawed on ice and cut into sections approximately 
30 mg in size; tissues were homogenized by sonication in 500 µL cell lysis solution (Bio-Rad, 
Hercules, CA) containing 20 mM phenylmethylsulfonyl fluoride (Sigma-Aldrich, St. Louis, MO). 
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Protein extraction was performed using methods adapted from Hulse et al. [29]. Thawed samples 
were vortexed for 1–3 s and centrifuged at 5000× g for 5 min at 4 °C. The supernatant was collected 
and tested for total protein content using a Pierce BCA Protein Assay Kit (Thermo Scientific, 
Waltham, MA), according to the manufacturer’s instructions. Absorbance values for total protein 
content were determined on an Infinite M1000 multimode plate reader (Tecan, Raleigh, NC). 
 
4.2.4 Cytokine and phosphoprotein measurement 
To standardize samples for total protein content, tissue homogenates were individually 
diluted to a total protein concentration of 900 µg/mL with cell lysis buffer (Bio-Rad). Cytokine 
and phosphoprotein measurements were performed using magnetic bead-based multiplex 
Inflammation Human ProcartaPlex panel assays (Invitrogen, Carlsbad, CA) and custom Bio-Plex 
human phosphoprotein multiplex kits. Targets were measured using a Bio-Plex 200 suspension 
array system and Pro II Wash Station (Bio-Rad), according to the manufacturer’s instructions. All 
cytokines and phosphoproteins measured in the study are listed in Tables 4.2 and 4.3 along with 

















Table 4. 2. Cytokine Targets Measured in Tissue Samples. All cytokines measured in this study 
are listed along with relevant functions during wound healing. Citations are noted in brackets. 
 
Cytokine Relevant Functions in Acute Wound Healing Response 
 
IL-1β Early initiator of infection-driven inflammation [2] 
IL-4 Anti-inflammatory cytokine that activates Stat6, suppressing cell death [42] 
IL-6 Initiator of early inflammatory response to implants and infection [2] 
IL-1α Early recruitment of immune cells in response to infection [2] 
IL-10 




Pro-inflammatory cytokine involved in adaptive immunity, produced by activated 
immune cells [43] 
IL-13 Th2-associated cytokine critical in tissue remodeling [44] 
IFN-γ 
Anti-inflammatory cytokine that has been associated with inhibition of wound 
healing [43] 
























Table 4. 3. Phosphoprotein Targets Measured in Tissue Samples. All phosphoproteins measured 
in this study are listed as well as the site of phosphorylation and roles in wound healing response. 
Citations are noted in brackets. 
 
Phosphoprotein (site) Relevant Functions in Acute Wound Healing Response 
p-CREB (Ser133) 
Inhibition of CREB via phosphorylation promotes wound closure 
[30] 
p-HSP27 (Ser78) Activation of HSP27 may inhibit stress-induced apoptosis [31] 
p-IκBα (Ser32/Ser36) Pro-wound healing, inhibits actions of NF-κB [32] 
p-MEK1 
(Ser217/Ser221) 
Essential for migration of epithelial layers [33] 
p-S6RP 
(Ser235/Ser236) 
Activated during proliferative growth phase [30] 
p-Smad2 
(Ser465/Ser467) 
Regulates keratinocyte migration during proliferation [34] 
p-Src (Tyr416) Promotes keratinocyte migration in wound healing [32] 
p-Syk (Tyr352) Important for cellular migration in wound healing [35] 
p-c-Jun (Ser63) Induces apoptosis of immune cells in skin wound healing [33] 
p-AKT (Ser473) Phosphorylation of AKT promotes wound closure [30] 
p-p53 (Ser15) 
Activated p53 accelerates cutaneous wound healing by increasing 
cell proliferation [36] 
p-p38 (Thr180/Tyr182) Activated p38 involved in muscle catabolism [32] 
p-p70S6K (Ser380) Growth factor associated with cell proliferation [37] 
p-PTEN (Ser380) Pro-apoptotic, inhibits acute wound healing [38] 
p-ZAP-70 (Tyr319) Stimulates cell migration during wound healing [35] 
p-BAD (Ser136) Phosphorylation of BAD activates pro-apoptotic functions [39] 
p-ERK1/2 
(Thr202/Tyr204) 
Important for early proliferative response in wound healing [37] 
p-GSK-3α/β 
(Ser21/Ser9) 
Controls wound healing and fibrosis progression [30] 
p-p90RSK (Ser380) 
Downstream effector of MEK/ERK pathway in wound healing, 
regulator of cell migration [40] 
p-VEGFR2 (Tyr1175) Stimulates angiogenic cascade during re-epithelialization [41] 





4.2.5 Data processing and statistical analysis 
Data were analyzed using Prism 5 (GraphPad, San Diego, CA) and SAS JMP (Cary, NC). 
Cytokine standard curves were generated using either a four- (4PL) or five-parameter logistic (5PL) 
regression model, depending on the individual protein. Cytokine concentrations are expressed as 
picograms of cytokine per milliliter of tissue homogenate (pg/mL). For purposes of network 
analyses, these values were normalized to the highest value for each cytokine. For phosphoproteins, 
relative phosphoprotein levels were measured via multiplex enzyme-linked immunosorbent assay 
(ELISA), and compared to negative control. These values were normalized to the highest value for 
each phosphoprotein. Contributions of cytokines and phosphoproteins were analyzed for the ATL 
and RTL layers. All four tissues from the ATL layer were averaged together to represent ATL 
depth. The three tissues from the RTL layer were averaged together to represent RTL depth. 
Samples with fluorescence intensity values below the lower limit of quantitation (LLOQ) or above 
the upper limit of quantitation (ULOQ) were omitted from statistical comparisons of cytokines and 
phosphoproteins. Outliers were identified using the 1.5 X interquartile range (IQR) rule and 
omitted from analysis [45]; these were removed on a case-by-case basis to exclude errant values 
that may have resulted due to assay variability. Two-way analysis of variance (ANOVA) with 
Bonferroni’s post-test was used to determine significant differences between primary TKA, aseptic 
TKR, and septic TKR tissue samples at each tissue depth, ATL and RTL. Data are expressed as 
the mean ± standard error of the mean (SEM). To examine any potential confounding factors in 
this cohort, Pearson correlations were analyzed between age, sex, and BMI and all 30 measured 
targets. A Bonferroni’s correction was applied, as described in [46], and the correlations were 
analyzed for statistical significance at p < 0.05. Although there are established correlations in 
literature between inflammatory mediators and age, sex, and BMI, there were no statistically 
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significant correlations observed for this study, which indicates that these parameters were not 
confounding factors (data not shown). 
 
4.2.6 Network evaluation with Ingenuity Pathway Analysis (IPA) 
 The normalized responses of each target were investigated with QIAGEN’s Ingenuity® 
Pathway Analysis (IPA®, QIAGEN, Redwood City). Proposed signaling networks of cytokines 
and phosphoproteins were created for all groups (primary TKA, aseptic TKR, septic TKR) at the 
ATL depth. All networks consist of nodes from the experimental dataset and literature-derived 
projected nodes likely to be involved, identified by Ingenuity Knowledge Base. Up- and down-
regulated responses are color coded using red and green, respectively. Briefly, IPA constructs 
networks building on “Focus Genes” or nodes that are highly interconnected [47]. Values from the 
experimental dataset influence which nodes are designated as “Focus Genes” and may alter the 
structure of the networks. IPA also reported top molecular and cellular functions related to the 
network, with corresponding scores (negative log10 [p-value of Fisher’s exact test]). The Fisher’s 
exact test (p-value) gives the likelihood of finding the identified Focus Genes by random chance 
in the Global Molecular Network used by IPA. 
 
4.2.7 Network centrality parameter analysis 
 Euclidean distances between pairs of normalized observations (cytokines and 
phosphoproteins) were determined for each group (primary, aseptic, septic) and depth (ATL and 
RTL). The definition of Euclidean distance is given in Equation 4.1: 
131 
 





  (4.1) 
 
where υ and ω represent the 2 responses for which the distance between is being calculated, and n 
signifies the replicate number. To construct networks of the relative responses of each group, 
Euclidean distances for each pair of nodes were used to calculate the node centrality parameter, 
radiality. Radiality is defined as: 
 
𝐶𝑟𝑎𝑑(𝜐) =




where G represents the network (N) diameter (maximal path length of the network), dist(υ,ω) is 
the shortest path between a pair of nodes υ and ω, and n is the number of nodes in the network 
(Equation 4.2). To allow for comparisons between networks, radiality values were normalized to 
the average radiality for all nodes in the network. Significant radiality values were identified using 
a threshold value of the average radiality ± the standard deviation. 
 
 Results 
4.3.1 Relative spatial cytokine responses 
Nine cytokines were measured in this study: IL-1α, IL-1β, IL-4, IL-6, IL-10, IL-12p70, IL-
13, IFN-γ, and TNF-α. The responses of these cytokines are shown in Figure 4.2. Cytokine levels 
were normalized across groups (primary TKA, aseptic TKR, septic TKR) and debridement depths 
(ATL, RTL) to the highest value for each cytokine. Normalizing by this method is important to 
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appropriately weight cytokines equally for network analysis rather than relying on raw 
concentrations. This weighting is performed to understand the contributions of each node to the 
network, relative to other nodes. Group-dependent differences were observed, as were spatial 
differences between debridement depths. Briefly, the aseptic TKR and septic TKR groups had 
higher cytokine responses than the primary TKA group for all cytokines. IL-1α, IL-1β, IL-4, and 
IL-6 had higher levels in septic TKR than aseptic TKR at a statistically significant level (p < 0.05). 
IL-10 was the only cytokine with a lower relative response in the septic TKR when compared to 
aseptic TKR at a statistically significant level (p < 0.05). IL-12p70 seemed to show the same trend, 
but was not significant at p < 0.05. There were also differences between ATL and RTL in septic 
TKR tissues. For IL-1α, IL-1β, and IL-4, there were statistically significant differences between 







































































































































































































Figure 4. 2. Relative cytokine levels measured in tissues from primary TKA, aseptic TKR, and 
septic TKR at adjacent tissue layer (ATL) and radial tissue layer (RTL) debridement depths. 
Relative cytokine responses (normalized to highest cytokine signal) were observed for all three 
patient groups: primary, aseptic, and septic at two debridement depths: ATL is closer to the knee 
joint, and RTL is approximately 1 cm removed from the knee joint. Statistically significant 
differences (p < 0.05) were determined by two-way ANOVA with Bonferroni’s post-test to 
examine group-dependent and spatially-dependent differences in cytokine relative response. 
Differences for the same group (i.e., septic) between ATL and RTL are marked with an asterisk 
(*). Differences between groups within a tissue layer are denoted with bars. Responses are shown 





4.3.2 Relative spatial phosphoprotein responses 
 To further investigate the impact of the observed cytokines on tissue response, twenty-one 
phosphoproteins were measured: p-CREB, p-HSP27, p-IκB-α, p-MEK1, p-S6RP, p-Smad2, p-Src, 
p-Syk, p-c-Jun, p-AKT, p-p53, p-p38, p-p70S6K, p-PTEN, p-ZAP-70, p-BAD, p-ERK1/2, p-
GSK-3α/β, p-p90RSK, pVEGFR2, and p-NF-κB (more information can be found in Table 4.3). 
The data are spread over Figures 4.3, 4.4 and 4.5. Figure 4.3 includes phosphoproteins most 
associated with proliferative wound healing processes [30,36,37,39]. Phosphoproteins in Figure 
4.4 have roles in cell migration and fibrotic processes [2,30,32,34,35,40,41]. Finally, Figure 4.5 
includes the phosphoproteins that have pro-apoptotic roles and have been associated with delayed 
wound healing through their involvement in muscle catabolism [33,38–40]. Most phosphoproteins 
exhibited higher responses in the primary TKA tissues than in aseptic TKR and septic TKR tissues, 
for both ATL and RTL depths, and many exhibited group-dependent differences, especially in 
ATL depth. Some exceptions to this trend were p-c-Jun and p-BAD, which had the highest 
responses in aseptic TKR, then septic TKR, followed by primary TKA; also, p-PTEN showed the 
highest response in septic tissues (Figure 4.5). Specific group-dependent comparisons are shown 
in Figures 4.3–4.5. 
  
 Tissue depths were also compared for phosphoproteins. Responses in the ATL were higher 
than responses in the RTL for most phosphoproteins. However, several proteins showed notably 
higher levels in RTL than ATL for at least one of the three tissue groups: p-BAD, p-Src, p-IκB-α, 
p-HSP27, p-ERK1/2, and p-VEGFR2 (Figures 4.3–4.5). Comparisons of ATL vs. RTL for each 
































































































































































Figure 4. 3. Relative levels of phosphoproteins associated with the proliferative processes in acute 
wound healing. Relative phosphoprotein responses (normalized to highest signal) were observed 
for all three patient groups: primary, aseptic, and septic at two debridement depths: ATL is closer 
to the knee joint, and RTL is approximately 1 cm removed from the knee joint. Statistically 
significant differences (p < 0.05) were determined by two-way ANOVA with Bonferroni’s post-
test to examine group-dependent and spatially-dependent differences in protein phosphorylation. 
Differences for the same group (i.e., septic) between ATL and RTL are marked with an asterisk 
(*). Differences between groups within a tissue layer are denoted with bars. Responses are shown 



































































































































































Figure 4. 4. Relative phosphoprotein levels associated with cell migration processes in acute 
wound healing. Relative phosphoprotein responses (normalized to highest signal) were observed 
for all three patient groups: primary, aseptic, and septic at two debridement depths: ATL is closer 
to the knee joint, and RTL is approximately 1 cm removed from the knee joint. Statistically 
significant differences (p < 0.05) were determined by two-way ANOVA with Bonferroni’s post-
test to examine group-dependent and spatially-dependent differences in protein phosphorylation. 
Differences for the same group (i.e., septic) between ATL and RTL are marked with an asterisk 
(*). Differences between groups within a tissue layer are denoted with bars. Responses are shown 









































































































Figure 4. 5. Relative levels of pro-apoptotic and inhibitory wound healing phosphoproteins in 
acute wound healing. Relative phosphoprotein responses (normalized to highest signal) were 
observed for all three patient groups: primary, aseptic, and septic at two debridement depths: ATL 
is closer to the knee joint, and RTL is approximately 1 cm removed from the knee joint. 
Statistically significant differences (p < 0.05) were determined by two-way ANOVA with 
Bonferroni’s post-test to examine group-dependent and spatially-dependent differences in protein 
phosphorylation. Differences for the same group (i.e., septic) between ATL and RTL are marked 
with an asterisk (*). Differences between groups within a tissue layer are denoted with bars. 




4.3.3 IPA-generated networks 
Networks for the three groups (primary TKA, aseptic TKR, and septic TKR) were 
constructed from the same set of cytokines and phosphoproteins for the ATL layer. The network 
connectivity varied greatly between the three groups (Figure 4.6). Qualitatively, the primary TKA 
network showed higher connectivity and more experimentally validated up- and down-regulation 
of targets, as shown by the red and green coloring, respectively. Further, the connections between 
targets, also known as “edges,” varied between the three groups. Edges denote connections 
between nodes; in IPA, direct relationships are shown by solid lines, and indirect relationships are 
shown by dotted lines. The primary TKA network showed 139 edges; 23 of these edges were direct, 
and 116 were indirect. For aseptic TKR, 65 total edges were identified: 4 direct, 61 indirect. For 
septic TKR, 61 total edges are shown: 4 direct and 57 indirect. IPA uses the experimental dataset 
to identify related IPA networks, shown in Table 4.4. A p-score is shown for each IPA network 
match, and the p-score is calculated based on the -log10(p-value) for the Fisher’s exact test. A 







Figure 4. 6. Ingenuity Pathway Analysis (IPA)-generated networks for primary TKA, aseptic TKR, 
and septic TKR groups based on cytokine and phosphoprotein datasets. Proposed networks used 
relative cytokine and phosphoprotein responses in the ATL depth, illustrating the differences in 
tissue responses for the three groups. The nodes are illustrated in a “heat map” coloring scheme, 
with red denoting up-regulation, green denoting down-regulation, and the intensity of color 
correlates to the intensity of relative response. The networks are supplemented with other nodes 
likely to be involved, as identified in the Ingenuity Knowledge Base. A solid line represents a 
direct interaction between two nodes, while a dotted line denotes an indirect relationship. 
 
 
Table 4. 4. Top 2 IPA Networks for Primary TKA, Aseptic TKR, and Septic TKR Groups. Network 
p-scores are calculated by IPA using the negative log10 (p-value) of Fisher’s exact test. The p-value 
describes the probability of finding the cytokines/phosphoproteins randomly in the databases 
utilized by IPA to construct the network. Networks with p-scores above the threshold of 21 are 
bolded. 
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4.3.4 Normalized radiality of all 30 nodes 
 
 Based on the ANOVA data and IPA-generated networks, all of these cytokine and 
phosphoprotein targets have roles to play in both infection response and wound healing. To further 
understand the most important targets, network centrality parameter analysis was performed by 
analyzing a network centrality parameter, radiality. Radiality values were determined for each 
cytokine and phosphoprotein node and normalized to the average radiality for the network (e.g., 
primary TKA, ATL layer). These values are presented in Tables 4.5 and 4.6. Changes in significant 
radiality outcomes can allow for a better understanding of the “drivers” of each network and 
deviations from normal response (Figure 4.7). Nodes with significant radiality values are bolded; 
the significance threshold used was the average radiality ± standard deviation. Based on previous 
work [49], we expect significant radiality outcomes with low radiality values to be the most likely 














Table 4. 5. Normalized Radiality of Nodes in the ATL Layer. Significant target values for each 
individual network are bolded (significance threshold: the average radiality ± standard deviation). 
Node ATL Primary TKA ATL Aseptic TKR ATL Septic TKR 
p-CREB 0.96 0.77 1.15 
p-HSP27 1.13 1.14 1.15 
p-IκBα 1.13 1.16 1.10 
p-MEK1 1.13 1.08 1.10 
p-S6RP 1.13 0.98 1.13 
p-Smad2 1.13 1.15 1.14 
p-Src 1.13 1.15 1.15 
p-Syk 1.13 1.11 0.95 
p-c-Jun 1.04 0.77 1.03 
p-AKT 1.10 0.99 1.08 
p-p53 1.13 1.00 1.06 
p-p38 1.13 1.05 1.06 
p-p70SK6 1.13 1.15 1.07 
p-PTEN 1.09 1.02 0.76 
p-ZAP-70 1.13 1.16 1.07 
p-BAD 0.96 0.77 1.15 
p-ERK1/2 1.13 1.15 1.13 
p-GSK-3a/b 1.13 1.16 1.12 
p-p90RSK 1.13 0.99 1.04 
p-VEGFR2 1.13 0.99 1.11 
p-NF-kB 1.13 1.16 1.09 
IL-1b 0.62 0.91 0.76 
IL-4 0.90 1.01 0.76 
IL-6 0.60 0.82 0.76 
IL-1a 0.63 1.15 0.76 
IL-10 0.73 0.79 1.02 
IL-12p70 0.84 0.77 1.06 
IL-13 0.84 0.77 0.76 
IFN-y 0.85 0.96 0.76 
TNF-a 0.85 0.93 0.76 
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Table 4. 6. Normalized Radiality of Nodes in the RTL Layer. Significant target values for each 
individual network are bolded (significance threshold: the average radiality ± standard deviation). 
Node RTL Primary TKA RTL Aseptic TKR RTL Septic TKR 
p-CREB 1.12 0.79 1.06 
p-HSP27 0.87 1.12 1.03 
p-IκBα 1.07 1.13 1.01 
p-MEK1 0.99 1.05 1.08 
p-S6RP 1.06 0.98 1.02 
p-Smad2 1.12 1.11 1.10 
p-Src 0.97 1.08 1.04 
p-Syk 1.01 0.96 0.94 
p-c-Jun 1.11 0.97 0.99 
p-AKT 0.80 1.12 1.09 
p-p53 0.97 1.07 1.00 
p-p38 1.11 1.08 1.06 
p-p70SK6 0.80 1.13 1.00 
p-PTEN 1.12 1.12 1.05 
p-ZAP-70 1.11 0.96 1.07 
p-BAD 1.12 0.79 1.06 
p-ERK1/2 0.83 1.09 1.11 
p-GSK-3a/b 1.12 1.12 1.02 
p-p90RSK 1.10 1.00 0.95 
p-VEGFR2 1.09 1.13 1.10 
p-NF-kB 1.04 1.12 1.04 
IL-1b 0.85 0.99 1.08 
IL-4 1.04 1.03 1.00 
IL-6 0.82 0.89 1.11 
IL-1a 0.84 1.09 1.11 
IL-10 0.95 0.64 0.70 
IL-12p70 0.96 0.92 1.07 
IL-13 1.01 0.74 0.59 
IFN-y 1.01 0.75 0.73 
TNF-a 1.00 1.00 0.80 
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 While several nodes were significant within each of the six networks, respectively, some 
nodes showed a group-dependent trend in significance (Tables 4.5 and 4.6). There were changes 
in significance between the native primary TKA response and aseptic or septic TKR responses. In 
the primary TKA networks, IL-1α, IL-1β, IL-6, and IL-10 gave significant low radiality outcomes 
for the ATL; p-HSP27, p-AKT, p-ERK1/2, IL-1α, IL-1β, and IL-6 were significant in the RTL. 
Differences for the aseptic TKR group include p-CREB, p-c-Jun, p-BAD, IL12p70, and IL-13 in 
the ATL; p-CREB, p-BAD, IL-10, IL-13, and IFN-γ for the RTL. Deviations in the septic TKR 
group include p-PTEN, IL-4, IL-13, IFN-γ, and TNF-α in the ATL layer and IL-10, IL-13, IFN-γ, 





















































































Figure 4. 7. Changes in significant nodes between groups for low radiality outcomes. Nodes with 
low radiality outcomes that differed between primary TKA response and aseptic/septic TKR 
responses are shown (significance threshold: the average radiality ± standard deviation). Boxes 
indicate significance at varying depths. IL-10 is shown in red to highlight its presence in all three 
groups: primary TKA, aseptic TKR, and septic TKR. IL-13 (green) and IFN-γ (blue) are also 





The cytokine and phosphoprotein targets measured in this study are known to be significant 
contributors to inflammatory responses in general [2], but the interconnected relationships of these 
targets remain to be elucidated for PJI. Further, many of these targets have not been studied on a 
tissue level for chronic inflammation and infection, so much of the dysregulation that occurs in 
immune response and wound healing processes remains unknown [12]. Relative cytokine and 
phosphoprotein responses were measured to understand the trends in response across three groups 
of patients: primary TKA, aseptic TKR, and septic TKR at two tissue depths: ATL and RTL. 
Higher relative cytokine levels were observed in either aseptic or septic TKR samples compared 
to primary TKA tissues. IL-1α, IL-1β, IL-4, and IL-6 showed infection-specific relative responses, 
with higher levels in septic TKR than both aseptic TKR and primary TKA (p < 0.05, Figure 4.2). 
These cytokines have been identified in literature as important early immune response mediators 
in PJI [50]. Additionally, there were spatial differences between ATL and RTL layers for IL-1α, 
IL-1β, IL-4, and IL-10 (Figure 4.2). The spatial discrepancies observed in this study suggested that 
the cytokine response is more robust in the ATL layer of septic tissues compared to the RTL. The 
spatial relationships were unclear for primary TKA and aseptic TKR using ANOVA comparisons 
(Figure 4.2). 
 
Phosphoproteins were also included in this analysis as many hold central roles in early 
infection response [4]. The phosphoproteome has not been thoroughly investigated for chronic 
joint inflammation and infection in PJI, but the relationships between cytokines and 
phosphoproteins may reveal important information considering the central role of these signaling 
proteins in cell cycle regulation [9], cell proliferation [36], inflammatory processes [49], and 
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wound healing [30]. Most phosphoproteins were found in higher levels in primary TKA tissues 
(Figures 4.3–4.5). While the septic TKR gave the highest response of most cytokines, it often 
showed the lowest levels of phosphoproteins (Figures 4.3–4.5). While many of the 
phosphoproteins tested are downstream targets of cytokines [2,32,33,38,40–43], decreased levels 
of wound healing-associated phosphoproteins have previously been observed in other studies 
[14,15]. Notable exceptions were p-c-Jun and p-BAD, which were highest in aseptic TKR, and p-
PTEN, which was highest in septic TKR (Figure 4.5). All three of these phosphoproteins have 
associated pro-apoptotic functions in acute wound healing [33,38,39], which may be related to 
their increased phosphorylation in aseptic and septic TKR tissues, respectively. Phosphoprotein 
levels also showed spatial trends between ATL and RTL at a statistically significant level (p < 
0.05) for p-IκB-α, p-GSK-3α/β, p-Smad2, and p-CREB (Figures 4.3,4.4). All four of these 
phosphoproteins are related to cell migration and proliferation, and have important roles for wound 
healing [30,32,34]. The results of this study showed higher levels for these phosphoproteins in the 
ATL of primary TKA, compared to RTL of primary TKA, which suggests tissues closer to the 
joint have increased wound healing activity (Figures 4.3,4.4). 
 
While traditional ANOVA comparisons gave information about the relative responses of 
cytokines and phosphoproteins, chronic inflammation and infection involve a series of deeply 
interconnected targets [3,12], which makes it difficult to fully understand the tissue responses 
when only considering each target in isolation. The ANOVA data alone do not fully explain which 
targets may be contributing most to the disruptions in responses observed in aseptic and septic 
TKR. IPA analysis was used to comparatively assess the connectivity between the three groups. 
IPA has proven to be a useful tool for visualizing the connectivity of different nodes (i.e., genes, 
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proteins, etc.) involved in networks [53]. Figure 4.6 illustrates the utility of IPA for comparing 
different networks qualitatively and depicts the differences between primary TKA, aseptic TKR, 
and septic TKR networks for each of the ATL layers. The primary TKA shows better connectivity 
between targets than aseptic TKR and septic TKR, suggesting there may be dysregulation 
occurring in both aseptic and septic TKR tissues (Figure 4.6). Additionally, Table 4.4 lists the top 
IPA network hits for each of the three networks. For proteomic analysis, a p-score above 21 is 
considered a good match [48]. Only the primary TKA network was able to make a match above 
this threshold. Based on the IPA analysis, both aseptic TKR and septic TKR networks show a lack 
of connectivity compared to primary TKA, which may prevent a reliable IPA network match 
(Table 4.4). 
 
A network centrality approach was also utilized to quantitatively assess which targets were 
close to (high radiality) or distant from (low radiality) the center of each of the networks. Radiality 
comparisons may reveal the most likely nodes contributing to the dysregulation observed in the 
IPA networks. Based on previous work in a rodent model of trauma [49], we expect that differences 
in nodes with low radiality between primary TKA response and aseptic or septic TKR responses 
may indicate the most likely causes of disruptions to normal signaling. In this study, low radiality 
outcomes were the most likely contributors to cell signaling dysregulation leading to chronic 
inflammation and infection. A significance threshold of the average radiality ± standard deviation 
was used to denote significant cytokine and phosphoprotein nodes (Tables 4.5 and 4.6). 




The primary TKA group represents the native response, as these tissues are not in contact 
with implants or infection that cause persistent inflammation [51,52]. In primary TKA, all 
significant nodes in the ATL had low radiality values, and all four were cytokines: IL-1α, IL-1β, 
IL-6, and IL-10. Within this network, these cytokines appear to be acting as regulatory molecules. 
IL-1α, IL-1β, and IL-6 are all pro-inflammatory cytokines vital for early inflammatory immune 
response [6,8]. The anti-inflammatory IL-10 is central for wound resolution [54]. In the RTL of 
primary TKA, nodes with significant low radiality values were p-HSP27, p-AKT, p-ERK1/2, IL-
1α, IL-1β, and IL-6 (Tables 4.5 and 4.6). This suggests that there is still a significant contribution 
of pro-inflammatory cytokines in healthy tissues spatially removed from the joint. p-HSP27, p-
AKT, and p-ERK1/2 have all been linked to early proliferative wound healing responses in trauma 
[55] and skin wounds [56]. Their low radiality outcomes suggested that these three 
phosphoproteins may be driving the tissue healing response. Additionally, in the RTL of primary 
TKA, seven phosphoproteins had significantly high radiality values (Table 4.6), suggesting that 
there is an organized wound healing response in tissues further away from the joint. 
 
The aseptic and septic TKR groups were compared to the primary TKA group to 
understand differences in radiality outcomes. In the aseptic ATL, nodes with significant low 
radiality outcomes were p-CREB, p-c-Jun, p-BAD, IL-6, IL-10, IL-12p70, and IL-13. Additionally, 
eight phosphoproteins and one cytokine had significant high radiality outcomes (Table 4.5). 
Overall, in the ATL of aseptic TKR, there appears to be a balance of regulated and dysregulated 
healing processes. In combination with the IPA network results, this suggested that dysregulation 
may be caused by reduced contributions for pro-inflammatory IL-1α and IL-1β and an increased 
role for anti-inflammatory IL-13 between primary TKA response and aseptic TKR response at the 
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joint (Figure 4.6). The pro-apoptotic actions of peripheral p-c-Jun and p-BAD [33,39], and 
inactivation of CREB [57] in aseptic TKR could also be driving these disruptions (Figures 4.6-
4.7). In the RTL of aseptic TKR, p-CREB, p-BAD, IL-10, IL-13, and IFN-γ gave significant low 
radiality outcomes (Table 4.6). The aseptic RTL tissues showed a shift to all significant nodes 
showing low radiality outcomes (Table 4.6). Compared to the primary RTL, there is a notable 
induction of anti-inflammatory cytokines IL-10, IL-13, and IFN-γ. Significance of p-CREB and 
p-BAD suggested these activated proteins may be promoting apoptosis [30,39] in presumably 
healthy aseptic tissues. Further, the coordinated healing response observed in primary RTL tissues 
is no longer present, as there were no significant high radiality outcomes in aseptic RTL (Table 
4.6). Even in the clinically “healthy” tissues for the aseptic group, there is a large amount of 
dysregulation present, and it appears to be primarily driven by these seven targets: p-c-Jun, p-
CREB, p-BAD, IL-10, IL-12p70, IL-13, and IFN-γ. 
 
In septic TKR, nodes with significant low radiality outcomes in the ATL were p-PTEN, 
IL-1α, IL-1β, IL-4, IL-6, IL-13, IFN-γ, and TNF-α. Notably, there were no significant high 
radiality outcomes (Table 4.5). While this may somewhat reflect the strong cytokine-dependent 
response observed in primary TKA, differences include increased contributions of anti-
inflammatory IL-4, IL-13, and IFN-γ, pro-inflammatory TNF-α, and pro-apoptotic p-PTEN in the 
septic TKR group. The ATL of septic TKR showed a notable induction of anti-inflammatory 
cytokines not observed in the primary TKA. In the septic RTL layer, IL-10, IL-13, IFN-γ, and 
TNF-α gave significant low radiality values. There were no significant outcomes with high 
radiality values in this network (Table 4.6). Additionally, there was no overlap in significant low 
radiality targets between primary TKA and septic TKR tissues at the RTL depth. This loss of 
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centrality for wound healing targets in the “healthy” septic TKR tissues reflects a disruption in 
normal response. 
 
There were some limitations to the study. A single surgeon collected all tissue samples for 
the cohort of patients involved. Treatment of PJI via debridement is a subjective assessment of 
tissue viability [28], so the delineation between “healthy” and “unhealthy” tissues may vary 
between surgeons. The results for the RTL depths of aseptic and septic TKR highlighted the 
disruptions still present in presumably healthy tissues removed from the joint, so a larger cohort 
of patients from different surgeons may aid future studies in analyzing these targets. Further, it is 
difficult to fully disentangle the inflammation present in native response from chronic 
inflammation and infection. The primary TKA group is expected to experience inflammation as a 
result of the surgery [58], which is why this study focused on outlining the differences between 
groups. These differences may not account for all inflammation occurring in the tissues, but the 
discrepancies between targets may help identify the dysregulation observed in aseptic and septic 
TKR. Differences in tissue composition (including bone, cartilage, and synovium) may also have 
played a role in introducing variability between cytokine and phosphoprotein levels; this study 
focused on including the most likely tissues taken from debridement, regardless of composition. 
Finally, the IPA analysis was only qualitatively useful in this case due to experimental constraints. 
While IPA can be used quantitatively for proteomics [59], the samples must be normalized to a 
control group. The primary TKA is not a true control, only a comparative group. In human subjects, 
we cannot ethically collect a true tissue control (i.e., healthy individuals with no inflammation 
present), which limited our ability to analyze via IPA. However, the qualitative comparison at the 
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joint still supported the network centrality analysis, and the IPA provided some confirmation of 
the roles of the targets involved. 
 
 Conclusion 
The acute intra- and extracellular responses to infection have been studied extensively, and 
these studies have provided valuable information for clinicians to develop diagnostics and 
therapeutics to combat these infections [50]. However, less is known about the dysregulation that 
occurs when inflammation and infections become chronic, which is the case in localized infections 
like PJI [12]. In this study, we aimed to define the impact of individual cytokines and 
phosphoproteins on chronic inflammation and infection in PJI using a network centrality parameter 
approach. Overall, network centrality analysis showed the native response in primary TKA tissues 
was dictated by a balance of pro- and anti-inflammatory cytokines. Tissues in the ATL were highly 
influenced by pro-inflammatory cytokines IL-1α, IL-1β, and IL-6 and anti-inflammatory IL-10. A 
variety of pro-inflammatory cytokines and wound healing phosphoproteins were central to the 
network in the RTL, and this response was reflective of normal tissue healing processes [8,30,43]. 
Deviations from this response were observed in both aseptic and septic TKR groups. In aseptic 
TKR tissues, a shift to increased peripheral roles for pro-apoptotic and anti-inflammatory targets 
was prevalent at both ATL and RTL tissue depths. In the septic ATL layer, pro-apoptotic p-PTEN 
and anti-inflammatory cytokines IL-4, IL-13, and IFN-γ showed significant losses of centrality 
compared to primary TKA. The high contributions of nodes with seemingly contradictory roles, 
combined with the loss of overall IPA network connectivity, highlights the dysregulation near the 
joint in septic TKR tissues. At the septic RTL depth, anti-inflammatory cytokines dominated the 
response, showing a hallmark absence of coordinated phosphoproteins linked to wound healing. 
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The radiality data as a whole suggested that disrupted signaling pathways are present for both 
aseptic and septic TKR, even in presumably “healthy” tissues. Targeting the proteins with 
significant radiality outcomes in chronic inflammation and infection may prove useful for 
developing more effective therapeutics, and future studies should focus on these proteins to 
promote tissue healing and infection resolution in PJI. 
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The work presented in this dissertation was aimed towards improving the understanding of 
chronic, localized infections through analysis of signal transduction pathways and represents one 
example of a basic research approach to a clinical problem, chronic infection. It began with an 
investigation of a clinical cohort to identify biomarkers of chronic PJI at two spatial gradients, then 
moved onto further probing of upstream and downstream effects of infection using an in vivo 
model. Finally, it culminated with validation of network centrality radiality analysis of signal 
mediators to understand drivers of disrupted responses observed in the clinical and in vivo studies. 
It represented a novel approach to prospective, tissue-level investigations of cell signaling changes 
in response to inflammatory stimuli, and the analyses demonstrated that distinct inflammatory 
immune and wound healing profiles exist in response to implants and chronic implant infections 
compared to native tissues. Based on this work, it was clear that both implants and chronic joint 
infections provoke cell signaling changes that negatively impact immune and wound healing 
responses on a tissue level.  
 
This research laid a foundation to better understand the tissue-level response to chronic 
infection, but there is more work to be done before it can be translated into the clinic. The final 
chapter of this dissertation will discuss important next steps for this work and implications for 
similar investigations. This work was the initial attempt to investigate the implications of tissue-
level disruptions caused by chronic infection (e.g., tissue viability), and the use of ‘omics 
technologies and newly emerging analytical techniques promise exciting progress in follow-up 
investigations of these signal transduction networks. The success in translation of this signal 
transduction work into the clinic will rely on comprehensive analyses of mediators involved, use 
of data integration techniques, and compatibility with expeditious results and interpretation. 
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 Localized vs. Systemic Investigations of Clinical Pathologies  
 An important consideration for signal transduction studies is whether to focus efforts on the 
localized response in individual organs or tissues or the systemic response in blood and other 
biological samples. The research goals of the study dictate the correct choice, and a variety of 
studies have investigated relationships between localized and systemic responses in disease states. 
Systemic measurements can prove beneficial for a variety of non-invasive applications, such as 
point-of-care diagnostics, in which samples can easily be acquired from blood or other fluids with 
minimal processing, providing a rapid means of obtaining clinical information. Studies concerned 
with infection or sepsis have concluded that both local and systemic information can be useful, 
and immune-related factors- such as cytokines- have been utilized as biomarkers on either level. 
Monitoring circulating levels of immune-related cytokines has proven useful for a range of 
clinically-relevant applications, including determining the presence of infection [1, 2], monitoring 
risk and severity of sepsis [3], and differentiating between types of infections [4, 5]. Systemic 
levels of immune mediators have also been pursued for other pathological conditions. Serum 
biomarkers have been identified in cancers to monitor drug efficacy [6] or predict adverse 
outcomes [7]. Concentrations of extracellular matrix proteins in serum have shown utility for 
monitoring tissue healing in chronic obstructive pulmonary disorder (COPD) [8]. Even tears [9] 
and saliva [10] have been used as mediums to better understand the immune response to stress and 
disease. Most of these systemic measurements are best suited for monitoring immune response 
over time or predicting adverse outcomes.  
 
 Localized investigations can highlight the ability of specific organs or tissue types to counter 
immune-related insults like infection, and these responses may differ with proximity, as 
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demonstrated in Chapters 2 and 3. Different tissues are composed of different cell types, and 
variability of responses may arise due to tissue composition, further highlighting the importance 
of considering a localized perspective for signal transduction research. Several studies have 
demonstrated differences between local and systemic immune environments [11], and localized 
profiles of immune mediators have been investigated in models of infection to understand the 
tissue-specific response [12, 13], including the work presented in this dissertation. Localized 
investigations have also been pursued for other conditions, and Hauser et al. demonstrated that the 
immune microenvironment differs between localized and circulating levels in response to human 
fracture and soft-tissue trauma [14]. Similarly, Currie et al. characterized the spatial gradients of 
immune and wound healing factors in a traumatic injury model in rodents to show that proximity 
dictates the response [15, 16]. Differences in localized and systemic profiles were investigated in 
organ failure with similar conclusions, that these localized perspectives offered tissue-specific 
insights relevant to disease management [17]. These studies illustrated that these responses might 
vary considerably depending on tissue type, and a localized approach is necessary to understand 
the specific responses of tissues and the effects on signal transduction cascades that arise following 
these insults. The spatial investigation conducted in this work demonstrated that spatial gradients 
exist in the tissue-level response to implants and infection, and tissues closer to the joint showed 
higher concentrations of cytokines and higher degrees of protein phosphorylation, so proximity is 
an important factor in the immune and wound healing responses. In the future, a comparison of 
serum would inform clinicians of systemic-level inflammation, which is likely higher in patients 
with aseptic and septic joints and could have negative implications for overall health. 
Understanding the systemic effects of joint implants and joint infections is an important 
consideration for Orthopaedists, but has not yet been addressed.  
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 Depending on an individual study’s intended outcomes, different spatial approaches may be 
suitable. Systemic responses are beneficial for biomarker identification and non-invasive 
monitoring of disease states, but studying localized responses in individual tissues or organs will 
be critical to making clinical assessments of tissue health (e.g., debridement) more objective. A 
localized approach was essential in this work to create a network of tissue-level responses to best 
understand the response to infection, and similar studies may benefit when aiming to identify 
healthy versus non-healthy tissues in response to stress, insults, and other diseases. 
 
 Integrating Multi-‘Omics Data to Approach Clinical Problems  
Probing biological networks on a tissue level in response to infection elucidated the 
interactions of highly interconnected targets, resulting in improved knowledge of the drivers of 
signaling and the potential points of disruption. In Chapter 4, changes in networks resulting from 
implant and infection were analyzed; Using network centrality radiality, it became possible to 
identify which targets were likely driving the dysregulated response observed in these 
inflammatory states. A thorough investigation of biological networks using mathematical 
modeling is a relatively new analysis strategy in developing improved diagnostic and therapeutics 
for many diseases [18, 19]. These network approaches often involve analyzing many targets 
simultaneously, and these data can be acquired from multiple ‘omics platforms. This creates a 
situation in which there are many more variables being tested than the number of replicates in the 
study, which has introduced new challenges for interpretation. 
 
Researchers must carefully consider what type of data to acquire and how best to integrate 
different data sources to support their hypothesis. To fully understand a disease or insult, it may 
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be necessary to investigate genetic factors, bioenergetics, immune response, or other elements. 
While acquiring more data is often beneficial, it has become essential to develop new methods to 
deal with these large data sets [20-22]. Translating multi-‘omics data into clinically-relevant 
information is the next challenge in identifying markers of tissue health in chronic infection, and 
these strategies could be applied to other investigations of cell signaling disruptions relevant to 
disease. While the initial research into tissue health in chronic infection was pursued in Chapter 4 
using network centrality, implementing other ‘omics techniques in the future- like metabolomics 
and transcriptomics- could better inform the distinction between healthy and non-healthy tissue, 
which is essential to develop useful clinical tools.  
 
Investigating metabolomic profiles related to implants and chronic infection is the logical 
next step towards improving tissue-level treatment. The cytokine and phosphoprotein data showed 
shifts in tissue responses, but they did not fully explain the implications for tissue health. Cellular 
metabolism changes are intimately linked to inflammatory response [30], and altered metabolite 
profiles have been observed in response to inflammatory stimuli [31]. Studies of polar metabolites 
have been used in literature to identify specific disruptions for a variety of pathological conditions 
[32], as many polar metabolites play key roles in growth, development, and conversion of nutrients. 
Targeting changes in these compounds could enlighten the distinct effects of chronic infection on 
these wound healing-related processes. Metabolomic analysis coupled to previously collected 
proteomic data on cytokines and phosphoproteins provides a means for pinpointing the specific 
infection-related disruptions between aseptic and septic joints. Based on literature investigations 
of skeletal muscle in other disease states, the prevailing hypothesis is that tissues responding to 
implants and infection will show lower levels of important polar metabolites related to energy 
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consumption (e.g., glucose, lactose). This shift will reflect the altered cellular states resulting from 
chronic exposure to inflammatory stimuli. Long-term metabolic health of these tissues is of the 
utmost importance to surgeons tasked with removing unhealthy and non-viable tissues. 
 
 New Technologies for Rapid Analysis  
 While many techniques are available to acquire data through multi-‘omics platforms, 
clinical relevance is dependent on ease of acquisition and interpretation. Biological network 
analysis of signal transduction networks is a complicated field, and researchers must keep this in 
mind when seeking to translate their findings into clinically-relevant information. The work 
presented in Chapters 2-4 heavily relied on multiplexed ELISA for data acquisition, but these 
assays required 4-20 hours for data acquisition alone. While the specificity of ELISA techniques 
was beneficial to lay the groundwork to understand targets of interest, this approach would not be 
appropriate for intra-operative use to treat these chronic infections, so future research should 
investigate the use of rapid analytical techniques to achieve this goal. 
 
Advances in the field, such as rapid ELISA platforms [23, 24], miniature field-applicable 
mass spectrometry [25], and other point-of-care testing have opened doors to advance the science 
of biomarker detection [26, 27],  and these platforms will prove essential to creating clinically-
relevant means of analysis. While basic science investigations, like the work presented here, can 
initially be used to identify markers of interest for disease, the ultimate goal is to provide a rapid, 
sensitive platform for acquisition with results that can be easily interpreted in the clinic. Future 
work to understand tissue viability in chronic infection or other disease states will benefit from 
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utilizing these newly emerging analytical tools to provide this information quickly. Shotgun 
metagenomic sequencing has been explored for fast identification of bacterial infection in synovial 
fluids in infection and showed faster results than traditional ELISAs [28]. Ultrafast qRT-PCR gene 
profiling coupled to machine learning algorithms has also demonstrated utility in establishing 
biomarkers of tissue health, and a study by Fillerova et al. represents one of the few attempts to 
characterize infection networks directly on a tissue level [29]. While this study included a smaller 
cohort, researchers achieved 94.5% sensitivity and 95.7% specificity for infection diagnosis using 
their algorithm and could provide diagnostic results within 45 minutes of sample collection.  
 
The future of signal transduction-focused research to understand chronic inflammation and 
infection will benefit from comparing local vs. systemic measurements and incorporating multi-
‘omics strategies to understand tissue health. Enrolling larger cohorts to include patients from 
multiple surgeons is the next step to tackling these problems, allowing a broader spectrum of 
expertise to delineate between healthy and unhealthy tissues and providing more tissue samples 
dedicated to other ‘omics platforms. Additional animal studies should be performed to investigate 
the temporal progression of immune and wound healing dysfunctions via transcriptomic and 
metabolomic analyses, which could provide insight into the transition from acute to chronic 
inflammatory states and enhance understanding of overall tissue viability relevant to surgical 
debridement. Rapid analytical platforms will be critical in developing clinical tools from the 
biomarkers identified in these studies to combat chronic inflammation and infection in the future. 
Approaching these clinically-relevant problems through signal transduction network investigation 
is key to improving current treatment methods, and the strategies utilized in these studies could be 
applied to other disease states. 
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APPENDIX A: CHAPTER 2 SUPPLEMENTARY FIGURES 
Table A. 1. Average cytokine concentrations in the adjacent tissue layer (ATL). Concentrations in 
the LG, F, T, and PC individual tissue locations were averaged to represent the response in the 
ATL. Standard error of the mean (SEM) and number of patients in each of the primary TKA, 
aseptic TKR, and septic TKR groups are also reported. 
 
  Primary TKA Aseptic TKR Septic TKR 
  ATL Avg SEM N ATL Avg SEM N ATL Avg SEM N 
IL-1α 1.26 0.34 6 14.25 3.96 5 38.70 8.75 6 
IL-1β 1.77 0.47 6 5.78 1.72 5 51.87 23.97 6 
IL-6 10.53 2.87 6 33.11 13.90 5 763.08 401.51 6 
IL-8 8.23 2.70 6 101.01 62.20 5 648.39 160.55 6 
MIP-1α 7.35 2.76 6 29.08 9.86 5 105.74 43.13 6 
MIP-1β 24.12 5.36 6 51.66 20.73 5 130.03 49.93 6 
MCP-1 151.55 27.13 6 359.90 174.07 5 475.19 195.67 6 
IL-4 7.48 1.59 6 21.04 3.78 5 28.37 5.03 6 
IL-10 0.89 0.17 6 8.38 0.23 5 5.71 1.38 6 
IL-12p70 6.57 1.62 6 33.21 10.88 5 21.51 5.74 6 
IL-13 1.98 0.42 6 10.14 2.59 5 9.52 2.65 6 
IL-17A 6.04 2.43 6 17.37 3.85 5 20.16 2.80 6 
TNF-α 18.68 3.44 6 79.12 20.42 5 93.12 16.60 6 
 
Table A. 2. Average cytokine concentrations in the radial tissue layer (RTL). Concentrations in 
the LG, F, and T individual tissue locations were averaged to represent the response in the RTL. 
Standard error of the mean (SEM) and number of patients in each of the primary TKA, aseptic 
TKR, and septic TKR groups are also reported. 
 
  Primary TKA Aseptic TKR Septic TKR 
  RTL Avg SEM N RTL Avg SEM N RTL Avg SEM N 
IL-1α 0.89 0.25 6 8.23 1.94 5 16.15 3.29 6 
IL-1β 1.80 0.47 6 5.10 0.96 5 13.41 5.29 6 
IL-6 6.10 1.35 6 11.58 5.31 5 288.59 205.91 6 
IL-8 6.06 1.91 6 46.37 21.58 5 350.06 188.02 6 
MIP-1α 8.76 3.62 6 23.76 13.68 5 42.20 17.64 6 
MIP-1β 17.23 3.50 6 36.52 19.98 5 79.97 27.68 6 
MCP-1 59.79 11.09 6 126.70 51.58 5 538.87 223.47 6 
IL-4 5.96 1.60 6 17.66 2.44 5 19.60 3.40 6 
IL-10 0.88 0.19 6 8.50 0.16 5 7.78 1.09 6 
IL-12p70 4.10 1.18 6 24.55 7.13 5 19.66 6.39 6 
IL-13 1.61 0.31 6 9.10 2.43 5 9.64 2.06 6 
IL-17A 4.37 1.75 6 14.90 3.88 5 17.31 2.71 6 
TNF-α 14.27 3.99 6 61.69 14.55 5 78.48 16.21 6 
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Figure A. 1. Cytokine profiles in localized tissues in infection-specific inflammation. Average 
cytokine concentration at individual tissue locations are shown for all groups. Two-way ANOVAs 
with Bonferroni’s post-test were conducted to test for significant differences between groups at 
each tissue depth (p<0.05). Significant differences between groups at a particular location are 
marked as: P denotes significant difference from primary TKA (N=6); A denotes significant 
difference from aseptic TKR (N=5); S denotes significant difference from septic TKR (N=6); all 


























































































































































































Figure A. 2. Cytokine profiles in localized tissues in implant-related inflammation. Average 
cytokine concentration at individual tissue locations are shown for all groups. Two-way ANOVAs 
with Bonferroni’s post-test were conducted to test for significant differences between groups at 
each tissue depth (p<0.05). Significant differences between groups at a particular location are 
marked as: P denotes significant difference from primary TKA (N=6); A denotes significant 
difference from aseptic TKR (N=5); S denotes significant difference from septic TKR (N=6); all 









































































































































































































































































































Figure A. 3. Cytokine calibration curves for human inflammatory cytokines. Calibration curves 
for cytokines were calculated using a four-parameter logistic (4PL) model in Bio-Plex Manager 
4.1.1. Five calibration standards were used for each cytokine, and averages of duplicates are shown 
with error bars denoting 2 standard deviations from the mean. Each graph title additionally shows 















































APPENDIX B: CHAPTER 3 SUPPLEMENTARY FIGURES 
Table B. 1. Cytokine concentrations for Sham, Implant Only, and Inf+Implant groups. Values are expressed as nanograms of cytokine 
per gram of tissue; average values ± SEM are listed. Note: all cytokines had associated error, but error is rounded to two decimal places. 
Significant comparisons (p<0.05) between locations for each cytokine within each group are denoted with letters; contralateral knee: A; 
operative leg proximal: B; operative knee: C; operative leg distal: D. For ease of reader, the significant comparisons between locations 
(p<0.05) are simply marked via superscript letters to denote which locations are different. All comparisons were done via two-way 
ANOVA followed by Bonferroni’s post-test. 
 
 
Sham Implant Only Inf+Implant 























































































































































































































































































X-RAY IMAGES OF RODENTS AT 21 DAYS POST-SURGERY 
 
Methods 
Grading and Analysis of X-Rays 
X-rays were taken on the day of operation as well as 21 days post-operation to compare joint 
conditions. X-rays at each time point were graded using methods established by Aktekin, et al. to 
evaluate the following parameters: periosteal reaction, diaphyseal widening, osteolysis, bone 
formation, sequestrum, joint effusion, and swelling. Results for each of the three groups: Sham, 
Implant Only, and Inf+Implant are displayed in Table S2. Representative x-ray images for each 
group are displayed, labeled with group. X-rays are shown at 21 days post-operation, and a red 
arrow points to the operative right knee joint. For some animals, staples can be seen on the right 
hind limb. For Implant Only and Inf+Implant groups, K-wire implant is denoted at the red arrow. 
X-Ray Analysis, Grading, and Results 
Table B. 2. X-Ray Grading Scores for Sham (N=6), Implant Only (N=6), and Inf+Implant (N=6) 
Groups at Post-Operative Day 0 (POD-0) and POD-21. X-rays were graded according to methods 
established by Aktekin, et al.  
 SHAM IMPLANT ONLY INF+IMPLANT 
 POD 0 POD 21 POD 0 POD 21 POD 0 POD 21 
Periosteal reaction 0.04167 0.08333 0.04167 0.08333 0 1.08333 
Diaphyseal widening 0 0 0 0.125 0 0.875 
Osteolysis 0.08333 0.08333 0.04167 0.20833 0 1.20833 
Bone formation 0 0 0 0.04167 0 0.75 
Sequestrum 0 0 0 0 0 0.16667 
Joint effusion 0 0 0 0 0 0.04167 








X-Ray Images of Sham, Implant Only, and Inf+Implant Groups 
Sham Group X-rays at 21-day Time Point 
 
Figure B. 1. X-ray images of Sham group rats at 21 days post-surgery. Radiographs are shown of 
animals in the sham group. In some animals, staples can be seen. Red arrows indicate operative 
knee.  
 
Implant Only Group X-rays at 21-day Time Point 
 
Figure B. 2. X-ray images of Impant Only group rats at 21 days post-surgery. Radiographs are 
shown of animals in the Implant Only group. In some animals, staples can be seen. Red arrows 









Figure B. 3. X-ray images of Inf+Impant group rats at 21 days post-surgery. Radiographs are 
shown of animals in the Inf+Implant group. In some animals, staples can be seen. Red arrows 

































































































































































































































































































Figure B. 4. Cytokine profiles in localized tissues in infection-specific inflammation. Average 
cytokine concentration in the serum of rats at the 21 day time point are shown for Sham, Implant 
Only, and Inf+Implant groups. Two-way ANOVAs with Bonferroni’s post-test were conducted to 








































































































































































































































Figure B. 5. Cytokine calibration curves for rodent inflammatory cytokines. Calibration curves 
for cytokines were calculated using a four-parameter logistic (4PL) model in Bio-Plex Manager 
4.1.1. Five calibration standards were used for each cytokine, and averages of duplicates are shown 
with error bars denoting 2 standard deviations from the mean. Each graph title additionally shows 
a number that indicates the bead region for that target in the Bio-Plex system.  
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